var title_f4_50_4896="Measles rash PI";
var content_f4_50_4896=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83849&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83849&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Measles rash",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 332px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Measles is an infection that causes a red rash on the face and body. It is caused by the measles virus. The spots in the rash can form red patches.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright Dr. Michael Bennish; reproduced with his permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4896=[""].join("\n");
var outline_f4_50_4896=null;
var title_f4_50_4897="Patient information: Enterocutaneous fistula (The Basics)";
var content_f4_50_4897=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/17214\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/27/29107\">",
"         Digestive system",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Enterocutaneous fistula (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/enterocutaneous-fistula-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H19859552\">",
"      <span class=\"h1\">",
"       What is an enterocutaneous fistula?",
"      </span>",
"      &nbsp;&mdash;&nbsp;An enterocutaneous fistula is an abnormal connection from the intestine to the skin (",
"      <a class=\"graphic graphic_figure graphicRef66110 \" href=\"UTD.htm?28/27/29107\">",
"       figure 1",
"      </a>",
"      ). It is a serious condition that might need to be treated in the hospital.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19859567\">",
"      <span class=\"h1\">",
"       What are the symptoms of enterocutaneous fistula?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Leakage of the intestines through an opening on the skin",
"       </li>",
"       <li>",
"        A swollen, tender belly",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Diarrhea",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19859582\">",
"      <span class=\"h1\">",
"       Is there a test for enterocutaneous fistula?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse should be able to tell if you have it by learning about your symptoms and doing an exam. But you might need tests that include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A CT scan &ndash; This is a special kind of X-ray.",
"       </li>",
"       <li>",
"        A fistulogram &ndash; For this test, the doctor injects a dye into the opening of the skin of the fistula and then takes an X-ray.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19859597\">",
"      <span class=\"h1\">",
"       How is an enterocutaneous fistula treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You will be treated with:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Fluids and medicines that go into a vein through a tube called an &ldquo;IV&rdquo; &nbsp;",
"       </li>",
"       <li>",
"        A tube (called a &ldquo;catheter&rdquo;) to help drain the fistula",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people need surgery to repair the fistula.",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?4/50/4897?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17214 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-684EC2BD62-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4897=[""].join("\n");
var outline_f4_50_4897=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19859552\">",
"      What is an enterocutaneous fistula?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19859567\">",
"      What are the symptoms of enterocutaneous fistula?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19859582\">",
"      Is there a test for enterocutaneous fistula?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19859597\">",
"      How is an enterocutaneous fistula treated?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/17214\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/27/29107\">",
"      Digestive system",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_50_4898="Aluminum chloride (dental): Drug information";
var content_f4_50_4898=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Aluminum chloride (dental): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F10458577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Hemodent&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F132123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Astringent;",
"     </li>",
"     <li>",
"      Hemostatic Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F2734371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Control of bleeding: Apply retraction cord as directed",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F2518276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15671462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15671463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F132110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cord, oral topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hemodent&trade;: 21% (7 ft [DSC]) [braided, medium-thin]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hemodent&trade;: 21% (7 ft [DSC]) [braided, thin]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hemodent&trade;: 21% (7 ft [DSC]) [twisted, #3]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hemodent&trade;: 21% (7 ft [DSC]) [twisted, #9]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hemodent&trade;: 21% (10 mL, 20 mL, 40 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F132101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F132111\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hemostatic",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F132121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No data reported.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F132113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No data reported",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F132105\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Application: Since large amounts of astringents may cause tissue irritation and possible damage, only small amounts should be applied.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F132108\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322972\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Certain Dri External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12% (35.5 mL): $4.62",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F132104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Precipitates tissue and blood proteins causing a mechanical obstruction to hemorrhage from injured blood vessels",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8610 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-C50D28AF5E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4898=[""].join("\n");
var outline_f4_50_4898=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10458577\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132123\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2734371\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2518276\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15671462\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15671463\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132110\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132101\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132111\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132121\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132113\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132105\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298719\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132108\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322972\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132104\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8610\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8610|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_50_4899="Missense mutation";
var content_f4_50_4899=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F55798&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F55798&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    Missense mutation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 281px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: United States National Library of Medicine. Available online at: file://ghr.nlm.nih.gov/handbook/illustrations/missense (Accessed on 1/12/2009).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4899=[""].join("\n");
var outline_f4_50_4899=null;
var title_f4_50_4900="Hiatal hernia PI";
var content_f4_50_4900=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F78791&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F78791&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 506px\">",
"   <div class=\"ttl\">",
"    Hiatal hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 486px; height: 635px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A sliding hernia happens when the top of the stomach squeezes up into the space above the diaphragm. This is the most common type of hiatal hernia.",
"    <br>",
"     A paraesophageal hernia happens when the top of the stomach folds up against the esophagus, creating a pouch. This is not very common, but it can be serious.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4900=[""].join("\n");
var outline_f4_50_4900=null;
var title_f4_50_4901="Atypical leiomyoma";
var content_f4_50_4901=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Histology of atypical uterine leiomyoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 443px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This atypical leiomyoma was biphasic. Panel A shows microscopic features of an atypical leiomyoma. Panel B shows a focus of severe nuclear atypia, comprised of pleomorphism, hyperchromasia, and multinucleation. Other features of malignancy are also present (ie, mitotic activity, geographic tumor necrosis).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4901=[""].join("\n");
var outline_f4_50_4901=null;
var title_f4_50_4902="Candesartan: Patient drug information";
var content_f4_50_4902=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Candesartan: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/48/38663?source=see_link\">",
"     see \"Candesartan: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/61/21462?source=see_link\">",
"     see \"Candesartan: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F144942\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Atacand&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F144943\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Candesartan&reg;;",
"     </li>",
"     <li>",
"      Atacand&reg;;",
"     </li>",
"     <li>",
"      CO Candesartan;",
"     </li>",
"     <li>",
"      JAMP-Candesartan;",
"     </li>",
"     <li>",
"      Mylan-Candesartan;",
"     </li>",
"     <li>",
"      PMS-Candesartan;",
"     </li>",
"     <li>",
"      Sandoz-Candesartan;",
"     </li>",
"     <li>",
"      Teva-Candesartan",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10019235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019237\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691384",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help a weak heart.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692146",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be given to you for other reasons. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701695",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to candesartan or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231030",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are on a low-salt or salt-free diet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4194403",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This is not a list of all drugs or health problems that interact with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4194405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take this drug with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10019241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2858939",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid driving and doing other tasks or actions that call for you to be alert until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4201327",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To lower the chance of feeling dizzy or passing out, rise slowly over a few minutes when sitting or lying down. Be careful climbing stairs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a salt substitute that has potassium, potassium-sparing diuretics, or potassium, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before you drink wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194393",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may not work as well in black patients. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are 65 or older, use this drug with care. You could have more side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10019242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4186184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor if any of these side effects or any other side effects bother you:",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697883",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Back pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698663",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698350",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sore throat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10019244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4186185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these side effects:",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4192387",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of liver problems like dark urine, feeling tired, not hungry, upset stomach or stomach pain, light-colored stools, throwing up, or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698068",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood in the urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4192394",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A burning, numbness, or tingling feeling that is not normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699103",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unable to pass urine or change in the amount of urine passed.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697997",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low mood (depression).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4270262",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fast or slow heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4186197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A heartbeat that does not feel normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698079",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever or chills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698248",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4193665",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shortness of breath, a big weight gain, swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699690",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects at",
"       <a href=\"file://www.fda.gov/medwatch\" target=\"_blank\">",
"        file://www.fda.gov/medwatch",
"       </a>",
"       .",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699689",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may report side effects to Health Canada's Canada Vigilance Program at 1-866-234-2345.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10019239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696083",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use this drug as ordered by your doctor. Read and follow the dosing on the label closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694819",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids after the test is over unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble swallowing, talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10019240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10019245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check with your pharmacist about how to throw out unused drugs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10019246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11653 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-197.136.42.3-9715D97815-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4902=[""].join("\n");
var outline_f4_50_4902=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144942\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144943\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019235\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019237\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019236\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019241\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019242\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019244\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019239\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019240\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019245\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019246\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?37/48/38663?source=related_link\">",
"      Candesartan: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/61/21462?source=related_link\">",
"      Candesartan: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_50_4903="Complications of circumcision";
var content_f4_50_4903=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Complications of circumcision",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/50/4903/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4903/contributors\">",
"     Jenny H Yiee, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4903/contributors\">",
"     Laurence S Baskin, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/50/4903/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4903/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4903/contributors\">",
"     Martin I Lorin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4903/contributors\">",
"     Duncan Wilcox, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/50/4903/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4903/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/50/4903/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Circumcision in the male refers to the surgical removal of the foreskin (ie, prepuce) of the penis. The procedure is centuries old and continues to be performed for a variety of religious, cultural, and medical reasons. Debate continues as to the utility of circumcision, as it remains uncertain whether the potential benefits of circumcision outweigh its known complications. Despite this controversy, circumcision is the most common operation in the United States (US). A survey in 1992 showed 77 percent of US-born men to be circumcised and 42 percent of non-US born men to be circumcised [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complications of circumcision and their management will be reviewed here. Circumcision technique and its risks and benefits are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15256?source=see_link\">",
"     \"Techniques for neonatal circumcision\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41705?source=see_link\">",
"     \"Neonatal circumcision: Risks and benefits\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Careful, meticulous attention to penile anatomy (",
"    <a class=\"graphic graphic_figure graphicRef76391 \" href=\"UTD.htm?19/0/19462\">",
"     figure 1",
"    </a>",
"    ) and the correct use of surgical equipment by trained clinicians can prevent most complications from circumcision.",
"   </p>",
"   <p>",
"    The rate of procedure-related complications during and after circumcision is approximately 2 to 5 per 1000 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most of these problems are readily treatable and cause no long-term effects. However, when complications occur, especially surgical complications, specialist referral may be required for evaluation and reoperation.",
"   </p>",
"   <p>",
"    The most common complications of male circumcision are bleeding and local infection [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/2,5,6\">",
"     2,5,6",
"    </a>",
"    ], followed by unsatisfactory cosmetic results (too little or too much skin removed) and surgical trauma or injury. Rare, but significant complications include life-threatening sepsis and meningitis, buried penis due to cicatrix formation, amputation of the glans, and necrotizing fasciitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These points were supported by a large study that compared complication rates among 136,000 circumcised and uncircumcised male infants [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/2\">",
"     2",
"    </a>",
"    ]. The frequency of complications and genitourinary problems during the first month of life among circumcised neonates was 0.19 percent, a figure comparable to the 0.24 percent rate of urinary tract infections (UTI) in uncircumcised neonates. The benefit of circumcision in reducing UTI is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41705?source=see_link&amp;anchor=H7#H7\">",
"     \"Neonatal circumcision: Risks and benefits\", section on 'Reduction in urinary tract infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following circumcision complications were noted in the 100,157 circumcised patients:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bleeding &ndash; 83 cases (0.08 percent), including 31 patients that required ligature to stop the hemorrhage, and 3 requiring transfusion",
"     </li>",
"     <li>",
"      Local infection &ndash; 62 cases (0.06 percent)",
"     </li>",
"     <li>",
"      Surgical",
"      <span class=\"nowrap\">",
"       trauma/injury",
"      </span>",
"      &ndash; 25 cases (0.02 percent)",
"     </li>",
"     <li>",
"      Urinary tract infections &ndash; 20 cases (0.02 percent)",
"     </li>",
"     <li>",
"      Bacteremia &ndash; 8 cases (less than 0.01 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MEDICAL COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bleeding is the most frequent complication following circumcision [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/2,9,10\">",
"     2,9,10",
"    </a>",
"    ]. It occurs from injury either to the frenular artery or dermal cut edges. The risk of severe bleeding is higher if there is an underlying coagulopathy. Therefore, neonatal petechiae or a family history of bleeding diathesis should prompt further evaluation before the procedure is undertaken. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/34/38442?source=see_link\">",
"     \"Treatment of hemophilia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There appears to be no difference in the risk of bleeding based on the technique chosen to perform the circumcision. This was illustrated in a randomized trial between Plastibell device circumcision and traditional sleeve technique circumcision that did not find any significant differences in hemorrhage rate [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/11\">",
"     11",
"    </a>",
"    ]. Some authors have reported that a worn Gomco clamp may predispose the infant to bleeding after circumcision due to inadequate crushing mechanisms. Therefore, the Gomco clamp should be carefully checked prior to each circumcision to ensure that there is no visible light between the bell and baseplate, and no stripped threads and screws [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/9\">",
"     9",
"    </a>",
"    ]. There should be a minimum distance of 0.085 inches between the arm and the base plate prior to tightening. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15256?source=see_link&amp;anchor=H12#H12\">",
"     \"Techniques for neonatal circumcision\", section on 'Technique'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following is our approach to managing bleeding following circumcision:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first step to control minor bleeding is the application of firm manual pressure for 10 to 20 minutes, followed by compression dressing or carefully applied circumferential bandage. Caution should be used when applying any circumferential bandage, as penile ischemia or urinary retention can occur.",
"     </li>",
"     <li>",
"      Manual compression is followed by topical application of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/57/37776?source=see_link\">",
"       lidocaine",
"      </a>",
"      with 1:100,000 epinephrine, fibrin glue, or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/46/20194?source=see_link\">",
"       silver nitrate",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/3\">",
"       3",
"      </a>",
"      ]. In our practice, we prefer manual compression followed by an application of dressing. If this fails to stop the bleeding, the next step is the topical administration (1 cc on a moist sponge) of 1:100,000 lidocaine with epinephrine, which hopefully results in vasoconstriction of the offending blood vessel(s). If a specific bleeding vessel can be identified, then fibrin glue",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      silver nitrate can be directly applied.",
"     </li>",
"     <li>",
"      If bleeding continues, fine absorbable sutures can be placed if a discrete source is visualized.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Caution should be used with any of these hemostatic methods in the region over the urethra to prevent inadvertent injury to the urethra. If these maneuvers fail, then a pediatric urology consult should be requested, as formal operative exploration may be required.",
"   </p>",
"   <p>",
"    Most commonly, bleeding after circumcision is a technical issue. If the described corrective measures are not effective, or the bleeding seems to be generalized, the patient should be evaluated for a coagulopathy. Evaluation that includes a complete blood count, including platelet count (prothrombin time), PTT (activated partial thromboplastin time), and fibrinogen level, will detect most of the major bleeding disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3722?source=see_link&amp;anchor=H18#H18\">",
"     \"Approach to the child with bleeding symptoms\", section on 'Diagnostic approach'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wound infection infrequently occurs after circumcision [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/2,6\">",
"     2,6",
"    </a>",
"    ]. It is usually mild and manifested by local inflammatory changes, which typically resolve with local topical triple antibiotic ointment [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/9,12\">",
"     9,12",
"    </a>",
"    ]. However, ulceration, suppuration, and systemic infection (eg, sepsis and meningitis) can occur and should be suspected in cases with systemic symptoms, such as fever, irritability, lethargy, or poor feeding [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. These cases require systemic antibiotics and surgical debridement.",
"   </p>",
"   <p>",
"    Although urinary tract infection (UTI) can occur in circumcised male infants, the frequency of UTI is significantly lower in circumcised infants compared with uncircumcised infants (0.02 versus 0.19 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/2\">",
"     2",
"    </a>",
"    ]. So UTI is not a complication of circumcision, but rather, a reduced risk of UTI is a benefit of circumcision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SURGICAL COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical complications include the following, some of which may require reoperation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Urethral injuries",
"     </li>",
"     <li>",
"      Glans injury",
"     </li>",
"     <li>",
"      Removal of excessive skin",
"     </li>",
"     <li>",
"      Inadequate skin removal",
"     </li>",
"     <li>",
"      Epidermal inclusion cyst",
"     </li>",
"     <li>",
"      Abnormal scarring, resulting in adhesions, cicatrix, or penile curvature",
"     </li>",
"     <li>",
"      Anesthetic complications",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Urethral complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urethral injury can occur if too much upward traction is placed on the foreskin prior to clamp application or entrapment of the glans in the clamp, possibly from incomplete separation of the glans from the inner prepuce. To prevent urethral injury, the coronal sulcus should be clearly delineated prior to commencement of the circumcision (",
"    <a class=\"graphic graphic_picture graphicRef62786 \" href=\"UTD.htm?25/21/25936\">",
"     picture 1",
"    </a>",
"    ). Urethral complications include urethrocutaneous fistulas (",
"    <a class=\"graphic graphic_picture graphicRef50774 \" href=\"UTD.htm?39/10/40096\">",
"     picture 2",
"    </a>",
"    ) and urethral meatal stenosis.",
"   </p>",
"   <p>",
"    If urethral injury is suspected, immediate pediatric urology consultation should be obtained. If the circumcision has not been completed at the time of injury, any prepuce should be left attached until the consultation, as this tissue may be useful in the repair of the urethra.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Urethrocutaneous fistulas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although urethrocutaneous fistula is most frequently associated with hypospadias correction, it may occur as a complication of circumcision (",
"    <a class=\"graphic graphic_picture graphicRef50774 \" href=\"UTD.htm?39/10/40096\">",
"     picture 2",
"    </a>",
"    ). Fistula correction requires a second operation that is performed six months after the initial procedure. These repairs are generally cosmetically and functionally successful [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26280?source=see_link&amp;anchor=H20#H20\">",
"     \"Hypospadias\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Meatal stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urethral meatal stenosis is almost always a condition of circumcised boys, and is rare in uncircumcised individuals. It is thought that stenosis develops from irritation of the newly exposed meatus, which usually occurs on the ventral lip [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/9,12\">",
"     9,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Typical presentations occur after toilet training and include an upward deflected urine stream, inability to direct the stream into the toilet, or a small stream with prolonged voiding time. Often boys will push their penis between their legs to direct the upward pointed urinary stream into the toilet. Other less common presentations include episodes of gross hematuria, dysuria, and urinary infection.",
"   </p>",
"   <p>",
"    A typical appearance is scarring on the ventral aspect of the meatus (",
"    <a class=\"graphic graphic_picture graphicRef86959 \" href=\"UTD.htm?34/18/35104\">",
"     picture 3",
"    </a>",
"    ); however, visual inspection of the meatus alone does not make the diagnosis. These patients should seek an outpatient consultation with a pediatric urologist for further evaluation, including direct observation of voiding.",
"   </p>",
"   <p>",
"    Treatment involves office or operating room meatotomy where a few millimeters of the ventral lip of the meatus are divided. Sutures are then usually used to reapproximate the cut edges.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Glans injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glans injury, including penile amputation, can occur if the glans is inadequately protected at the time the foreskin is excised, or if the glans is caught in the clamp apparatus when the foreskin is excised. These injuries have been described with Sheldon clamps [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/16\">",
"     16",
"    </a>",
"    ] and Mogen clamps [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/17\">",
"     17",
"    </a>",
"    ]. Gomco clamps and Plastibell's devices should theoretically protect the glans via the bell attachment; however, such injuries can still occur if the bell is ill-fitting, displaced, or the incision is made at the incorrect location on the device.",
"   </p>",
"   <p>",
"    If the glans is amputated, the tissue should be wrapped in saline-soaked gauze and placed indirectly on ice for transport. The patient should be transferred immediately to a referral center, as successful reattachment is possible if performed within eight hours of injury (",
"    <a class=\"graphic graphic_picture graphicRef53520 \" href=\"UTD.htm?8/40/8832\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/12,16,17\">",
"     12,16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If the glans is injured but still attached, immediate pediatric urology consultation should be obtained. In mild cases where urethra and corpora cavernosa are not injured, conservative management may be possible (",
"    <a class=\"graphic graphic_picture graphicRef69887 \" href=\"UTD.htm?27/13/27871\">",
"     picture 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Another possible mechanism of glans injury can occur with necrosis of the glans secondary to ischemia from a slipped Plastibell device ring. The Plastibell ring should ordinarily sit over the glans for about one week until excess skin sloughs and the ring falls off (",
"    <a class=\"graphic graphic_figure graphicRef63926 \" href=\"UTD.htm?5/41/5777\">",
"     figure 2",
"    </a>",
"    ). If the ring is over-sized, it can slip proximal to the glans onto the penile shaft where it can cause constriction. If it cannot be removed easily, ring-cutters found in emergency departments can be employed to cut the Plastibell ring off.",
"   </p>",
"   <p>",
"    The glans can also be injured when electrocautery is used. Thermal injuries can cause devastating, irreversible destruction that can leave the penis unsalvageable [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/18\">",
"     18",
"    </a>",
"    ]. For this reason, electrocautery should be used judiciously by experienced clinicians only or not at all.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Excessive skin removal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Too much penile shaft skin can be removed if upward traction on the prepuce is overly aggressive prior to excision, or if the glans is inadequately separated from the inner prepuce (",
"    <a class=\"graphic graphic_picture graphicRef62786 \" href=\"UTD.htm?25/21/25936\">",
"     picture 1",
"    </a>",
"    ). Excessive skin removal may result in a denuded penile shaft (",
"    <a class=\"graphic graphic_picture graphicRef86961 \" href=\"UTD.htm?3/49/3860\">",
"     picture 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In many cases, conservative therapy consisting of wet to dry, or antibiotic ointment dressings results in adequate healing by secondary intention [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/9,12\">",
"     9,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    More severe cases require pediatric urology referral for either primary reapproximation or skin grafting. If primary reapproximation is to be attempted, it is imperative that the length of skin prior to closure is adequate for function including erection. If adequate inner prepuce is left, this can be primarily sutured to the penile shaft skin to provide coverage. This method will leave the penis with the slightly altered appearance inherent with inner preputial skin. For cases with inadequate skin for reapproximation, split thickness and full thickness skin have been performed [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Too little skin removed",
"    </span>",
"    &nbsp;&mdash;&nbsp;If insufficient foreskin is removed, the penis may not appear to be circumcised or the result may appear asymmetric (",
"    <a class=\"graphic graphic_picture graphicRef86960 \" href=\"UTD.htm?17/51/18225\">",
"     picture 7",
"    </a>",
"    ), leading to a displeasing cosmetic appearance [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/9\">",
"     9",
"    </a>",
"    ]. These cases should be referred to a pediatric urologist for further consultation to determine the need for circumcision revision, which is not usually medically mandated. At that time, the risks of a reoperation need to be weighed against the benefits of improved cosmetic appearance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Epidermal inclusion cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidermal inclusion cyst occurs when an island of skin is left to heal underneath the skin of the penile shaft. Cysts usually are diagnosed by physical examination. Treatment consists of formal excision of the entire cyst.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Scarring complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scarring complications after circumcision include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Minor adhesions",
"     </li>",
"     <li>",
"      Dense adhesions referred to as skin bridges",
"     </li>",
"     <li>",
"      Cicatrix formation",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Minor adhesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minor adhesions are commonly found after circumcisions [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/20\">",
"     20",
"    </a>",
"    ], and consist of tiny areas of fusion between the foreskin and corona (",
"    <a class=\"graphic graphic_picture graphicRef62786 \" href=\"UTD.htm?25/21/25936\">",
"     picture 1",
"    </a>",
"    ). These adhesions usually resolve with time [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/21\">",
"     21",
"    </a>",
"    ]. Gentle retraction can be used to lyse the adhesion, followed by application of topical petroleum jelly or antibiotic ointment for one week to prevent new adhesions from developing. If gentle traction is not effective,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/7/28791?source=see_link\">",
"     betamethasone",
"    </a>",
"    0.05 percent ointment, which is used to treat adhesions in patients with phimosis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/22\">",
"     22",
"    </a>",
"    ], can also be used in minor adhesions after circumcision. It may be applied to the adhesion twice a day for six weeks, and is generally effective [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most minor adhesions can be prevented by instructing the parents to retract and clean any skin covering the glans, beginning a day or two after circumcision when acute bleeding is unlikely, and keratinization of the glans has begun.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Skin bridges",
"    </span>",
"    &nbsp;&mdash;&nbsp;More complex fusion where the foreskin adheres higher up on the glans may result in dense adhesions, referred to as skin bridges (",
"    <a class=\"graphic graphic_picture graphicRef66155 \" href=\"UTD.htm?21/10/21666\">",
"     picture 8",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Skin bridges can be visually displeasing and cause tethering of the penis. These boys should be referred to a pediatric urologist for possible lysis of adhesions via scalpel after the application of a topical anesthetic [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/9,12\">",
"     9,12",
"    </a>",
"    ]. This procedure may be performed in the office or in the operating room.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Cicatrix",
"    </span>",
"    &nbsp;&mdash;&nbsp;A cicatrix is a circumferential scar that usually develops at the incision line. It is commonly associated with a hidden penis, in which the scar prevents the penis from being exposed. Over time, this can result in trapping of urine, which causes more inflammation and worsening of the scar (",
"    <a class=\"graphic graphic_picture graphicRef75225 \" href=\"UTD.htm?5/55/6000\">",
"     picture 9",
"    </a>",
"    ). In cases with a trapped penis by a cicatrix, outpatient referral to a pediatric urologist is necessary assessment and intervention. Revision involves excision of the scar, often with skin flap coverage to substitute for a paucity of penile shaft skin. Adequate results can usually be achieved (",
"    <a class=\"graphic graphic_picture graphicRef75225 \" href=\"UTD.htm?5/55/6000\">",
"     picture 9",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/12,23\">",
"     12,23",
"    </a>",
"    ]. One study has reported the use of topical",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/7/28791?source=see_link\">",
"     betamethasone",
"    </a>",
"    to successfully treat cicatrix without the need for surgery in 9 of 14 subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hidden penis due to a cicatrix needs to be distinguished from that commonly seen in overweight males with a large suprapubic fat pad. In overweight patients without any underlying pathology, the penis can be expressed simply by pushing under the pubic bone (",
"    <a class=\"graphic graphic_picture graphicRef71356 \" href=\"UTD.htm?24/22/24943\">",
"     picture 10",
"    </a>",
"    ). Circumcision in obese children or those with a relatively small phallus is generally discouraged during infancy because of the tendency for the penis to become buried [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4903/abstract/9,25\">",
"     9,25",
"    </a>",
"    ]. If circumcision is performed, then care must be taken to ensure that the parents expose the penis once or twice a day with application of antibiotic ointment until healing resolves to prevent cicatrix development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Anesthetic complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, most neonatal circumcisions are performed in the nursery and not in an operating room setting. In this setting, the most commonly used anesthesia include penile nerve blocks and topical anesthesia. These analgesic measures and their potential complications are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15256?source=see_link&amp;anchor=H8#H8\">",
"     \"Techniques for neonatal circumcision\", section on 'Pain control'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?28/36/29249?source=see_link\">",
"       \"Patient information: Circumcision in baby boys (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/5/1107?source=see_link\">",
"       \"Patient information: Circumcision in baby boys (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Circumcision is the most common surgery performed in the United States.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Careful, meticulous attention to penile anatomy (",
"      <a class=\"graphic graphic_figure graphicRef76391 \" href=\"UTD.htm?19/0/19462\">",
"       figure 1",
"      </a>",
"      ) and correct use of surgical equipment by trained clinicians can prevent most complications. When complications occur, specialist referral may be required.",
"     </li>",
"     <li>",
"      The rate of procedure-related complications during and after circumcision is approximately 2 to 5 per 1000 cases. Most complications are readily treatable and cause no long-term effects. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common complications associated with circumcision are bleeding and infection. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Medical complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical complications are less common and include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Urethral complications, including urethrocutaneous fistulas and urethral meatal stenosis (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Urethral complications'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Glans injury including penile amputation (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Glans injury'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Removal of excessive skin that may result in a denuded penile shaft (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Excessive skin removal'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Inadequate skin removal that may result in an unsatisfactory cosmetic appearance",
"     </li>",
"     <li>",
"      Epidermal inclusion cyst",
"     </li>",
"     <li>",
"      Adhesions can vary from mild adhesions of tiny areas of fusion between the foreskin and corona, which can be treated conservatively, to dense adhesions (also referred to as skin bridges) that may cause tethering of the penis and usually require surgical lysis (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Minor adhesions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Skin bridges'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Cicatrix is a circumferential scar that usually develops at the incision line and is often associated with a hidden penis (see",
"      <a class=\"local\" href=\"#H18\">",
"       'Cicatrix'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Anesthetic complications of circumcision are reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15256?source=see_link&amp;anchor=H8#H8\">",
"       \"Techniques for neonatal circumcision\", section on 'Pain control'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/1\">",
"      Laumann EO, Masi CM, Zuckerman EW. Circumcision in the United States. Prevalence, prophylactic effects, and sexual practice. JAMA 1997; 277:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/2\">",
"      Wiswell TE, Geschke DW. Risks from circumcision during the first month of life compared with those for uncircumcised boys. Pediatrics 1989; 83:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/3\">",
"      Gee WF, Ansell JS. Neonatal circumcision: a ten-year overview: with comparison of the Gomco clamp and the Plastibell device. Pediatrics 1976; 58:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/4\">",
"      Harkavy KL. The circumcision debate. Pediatrics 1987; 79:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/5\">",
"      Neonatal circumcision revisited. Fetus and Newborn Committee, Canadian Paediatric Society. CMAJ 1996; 154:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/6\">",
"      Williams N, Kapila L. Complications of circumcision. Br J Surg 1993; 80:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/7\">",
"      Scurlock JM, Pemberton PJ. Neonatal meningitis and circumcision. Med J Aust 1977; 1:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/8\">",
"      Woodside JR. Necrotizing fasciitis after neonatal circumcision. Am J Dis Child 1980; 134:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/9\">",
"      Baskin LS, Canning DA, Snyder HM, Duckett JW. Treating complications of circumcision. Pediatr Emerg Care 1996; 12:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/10\">",
"      Weiss HA, Larke N, Halperin D, Schenker I. Complications of circumcision in male neonates, infants and children: a systematic review. BMC Urol 2010; 10:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/11\">",
"      Bastos Netto JM, de Ara&uacute;jo JG Jr, de Almeida Noronha MF, et al. Prospective randomized trial comparing dissection with Plastibell&reg; circumcision. J Pediatr Urol 2010; 6:572.",
"     </a>",
"    </li>",
"    <li>",
"     Elder J. Abnormalities of the genitalia in boys and their surgical management. In: Campbell-Walsh Urology, 4th ed, Wein A, Kavoussi L, Novick A (Eds), Elsevier, Philadelphia 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/13\">",
"      Pieretti RV, Goldstein AM, Pieretti-Vanmarcke R. Late complications of newborn circumcision: a common and avoidable problem. Pediatr Surg Int 2010; 26:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/14\">",
"      Krill AJ, Palmer LS, Palmer JS. Complications of circumcision. ScientificWorldJournal 2011; 11:2458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/15\">",
"      Baskin LS, Canning DA, Snyder HM 3rd, Duckett JW Jr. Surgical repair of urethral circumcision injuries. J Urol 1997; 158:2269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/16\">",
"      Gluckman GR, Stoller ML, Jacobs MM, Kogan BA. Newborn penile glans amputation during circumcision and successful reattachment. J Urol 1995; 153:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/17\">",
"      Sherman J, Borer JG, Horowitz M, Glassberg KI. Circumcision: successful glanular reconstruction and survival following traumatic amputation. J Urol 1996; 156:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/18\">",
"      Gearhart JP, Rock JA. Total ablation of the penis after circumcision with electrocautery: a method of management and long-term followup. J Urol 1989; 142:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/19\">",
"      Thompson JH, Zmaj P, Cummings JM, Steinhardt GF. An approach for using full thickness skin grafts for complex penile surgeries in children. J Urol 2006; 175:1869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/20\">",
"      Van Howe RS. Variability in penile appearance and penile findings: a prospective study. Br J Urol 1997; 80:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/21\">",
"      Ponsky LE, Ross JH, Knipper N, Kay R. Penile adhesions after neonatal circumcision. J Urol 2000; 164:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/22\">",
"      Palmer LS, Palmer JS. The efficacy of topical betamethasone for treating phimosis: a comparison of two treatment regimens. Urology 2008; 72:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/23\">",
"      Casale AJ, Beck SD, Cain MP, et al. Concealed penis in childhood: a spectrum of etiology and treatment. J Urol 1999; 162:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/24\">",
"      Palmer JS, Elder JS, Palmer LS. The use of betamethasone to manage the trapped penis following neonatal circumcision. J Urol 2005; 174:1577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4903/abstract/25\">",
"      Ero��lu E, Bastian OW, Ozkan HC, et al. Buried penis after newborn circumcision. J Urol 2009; 181:1841.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6587 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-1F43DE5731-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4903=[""].join("\n");
var outline_f4_50_4903=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MEDICAL COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Bleeding",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SURGICAL COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Urethral complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Urethrocutaneous fistulas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Meatal stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Glans injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Excessive skin removal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Too little skin removed",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Epidermal inclusion cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Scarring complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Minor adhesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Skin bridges",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Cicatrix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Anesthetic complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6587\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6587|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/0/19462\" title=\"figure 1\">",
"      Penis anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/41/5777\" title=\"figure 2\">",
"      Plastibell procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6587|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/21/25936\" title=\"picture 1\">",
"      Penile adhesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/10/40096\" title=\"picture 2\">",
"      Urethrocutaneous fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/18/35104\" title=\"picture 3\">",
"      Circumcision complication - Meatal stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/40/8832\" title=\"picture 4\">",
"      Penile glans amputation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/13/27871\" title=\"picture 5\">",
"      Partial penile glans injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/49/3860\" title=\"picture 6\">",
"      Circumcision complication - Loss penile shaft skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/51/18225\" title=\"picture 7\">",
"      Circumcision complication - Excess ventral skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/10/21666\" title=\"picture 8\">",
"      Circumcision skin bridges",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/55/6000\" title=\"picture 9\">",
"      Cicatrix concealed penis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/22/24943\" title=\"picture 10\">",
"      Hidden penis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3722?source=related_link\">",
"      Approach to the child with bleeding symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26280?source=related_link\">",
"      Hypospadias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41705?source=related_link\">",
"      Neonatal circumcision: Risks and benefits",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/5/1107?source=related_link\">",
"      Patient information: Circumcision in baby boys (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/36/29249?source=related_link\">",
"      Patient information: Circumcision in baby boys (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15256?source=related_link\">",
"      Techniques for neonatal circumcision",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/34/38442?source=related_link\">",
"      Treatment of hemophilia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_50_4904="Ethanol (topical and injection): Drug information";
var content_f4_50_4904=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ethanol (topical and injection): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19703?source=see_link\">",
"    see \"Ethanol (topical and injection): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F131116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Epi-Clenz&trade; [OTC];",
"     </li>",
"     <li>",
"      Gel-Stat&trade; [OTC];",
"     </li>",
"     <li>",
"      GelRite&trade; [OTC];",
"     </li>",
"     <li>",
"      Isagel&reg; [OTC];",
"     </li>",
"     <li>",
"      Lavacol&reg; [OTC];",
"     </li>",
"     <li>",
"      Prevacare&reg; [OTC];",
"     </li>",
"     <li>",
"      Protection Plus&reg; [OTC];",
"     </li>",
"     <li>",
"      Purell&reg; 2 in 1 [OTC];",
"     </li>",
"     <li>",
"      Purell&reg; Lasting Care [OTC];",
"     </li>",
"     <li>",
"      Purell&reg; Moisture Therapy [OTC];",
"     </li>",
"     <li>",
"      Purell&reg; with Aloe [OTC];",
"     </li>",
"     <li>",
"      Purell&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F131117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Biobase-G&trade;;",
"     </li>",
"     <li>",
"      Biobase&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F131133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidote;",
"     </li>",
"     <li>",
"      Pharmaceutical Aid",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F131118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Antiseptic:",
"     </b>",
"     <i>",
"      Liquid denatured alcohol:",
"     </i>",
"     Topical: Apply 1-3 times/day as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Therapeutic neurolysis (nerve or ganglion block):",
"     </b>",
"     <i>",
"      Dehydrated alcohol injection 98%:",
"     </i>",
"     Intraneural: Dosage variable depending upon the site of injection (eg, trigeminal neuralgia: 0.05-0.5 mL as a single injection per interspace vs subarachnoid injection: 0.5-1 mL as a single injection per interspace);  single doses &gt;1.5 mL are seldom required",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Replenishment of fluid and carbohydrate calories:",
"     </b>",
"     <i>",
"      Dehydrated alcohol infusion:",
"     </i>",
"     Alcohol 5% and dextrose 5%: 1-2 L/day by slow infusion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Septal ablation for HOCM (unlabeled use; Maron, 2003; Sorajja, 2012): Intracoronary (via balloon catheter):",
"     </b>",
"     Dosage variable depending on septal anatomy and rate of contrast wash-out: 1-3 mL of at least 95% concentration infused slowly into septal perforator.",
"     <b>",
"      Note:",
"     </b>",
"     Smaller amounts may reduce the size of the septal infarct and incidence of complications (eg, complete heart block).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of methanol or ethylene glycol ingestion (unlabeled use):",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     I.V. administration is the preferred route; continue therapy until ethylene glycol and/or methanol is no longer detected or levels are &lt;20 mg/dL",
"     <b>",
"      and",
"     </b>",
"     the patient is asymptomatic",
"     <b>",
"      and",
"     </b>",
"     metabolic acidosis has been corrected. If ethylene glycol and/or methanol levels are not available in a timely manner, continue therapy until the estimated time of clearance of ethylene glycol and/or methanol has elapsed",
"     <b>",
"      and",
"     </b>",
"     the patient is asymptomatic with a normal pH. If patient has coingested ethanol, measure the baseline serum ethanol concentration and adjust the ethyl alcohol loading dose based on results to achieve a serum ethanol level of ~100 mg/dL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Absolute ethyl alcohol [98% (196 proof) = 77.4 g EtOH/dL]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Contact the Poison Control Center for options related to compounding I.V. ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Initial: 600-700 mg/kg [equivalent to 7.6-8.9 mL/kg using a",
"     <b>",
"      10% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Maintenance: Goal of therapy is to maintain serum ethanol levels &gt;100 mg/dL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Nondrinker: 66 mg/kg/hour [equivalent to 0.83 mL/kg/hour using a",
"     <b>",
"      10% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Chronic drinker: 154 mg/kg/hour [equivalent to 1.96 mL/kg/hour using a",
"     <b>",
"      10% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment for hemodialysis:",
"     </b>",
"     Maintenance dose:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Nondrinker: 169 mg/kg/hour [equivalent to 2.13 mL/kg/hour using a",
"     <b>",
"      10% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Chronic drinker: 257 mg/kg/hour [equivalent to 3.26 mL/kg/hour using a",
"     <b>",
"      10% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral:",
"     <b>",
"      Note:",
"     </b>",
"     Solution must be diluted to a &le;20% concentration with water or juice and administered orally or via a nasogastric tube.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Initial: 600-700 mg/kg [equivalent to 0.78-0.9 mL/kg using a",
"     <b>",
"      98% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Maintenance: Goal of therapy is to maintain serum ethanol levels &gt;100 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Nondrinker: 66 mg/kg/hour [equivalent to 0.09 mL/kg/hour using a",
"     <b>",
"      98% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Chronic drinker: 154 mg/kg/hour [equivalent to 0.20 mL/kg/hour using a",
"     <b>",
"      98% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment for hemodialysis:",
"     </b>",
"     Maintenance dose:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Nondrinker: 169 mg/kg/hour [equivalent to 0.22 mL/kg/hour using a",
"     <b>",
"      98% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Chronic drinker: 257 mg/kg/hour [equivalent to 0.33 mL/kg/hour using a",
"     <b>",
"      98% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of fat occlusion of central venous catheters (unlabeled use):",
"     </b>",
"     <i>",
"      Dehydrated alcohol injection:",
"     </i>",
"     I.V. (see institutional-based protocol for catheter clearance assessment, the following assessment is a general methodology): Up to 3 mL of ethanol 70% (maximum: 0.55 mL/kg); the volume to instill is equal to the internal volume of the catheter",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F131129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19703?source=see_link\">",
"      see \"Ethanol (topical and injection): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Antiseptic:",
"     </b>",
"     <i>",
"      Liquid denatured alcohol:",
"     </i>",
"     Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of methanol or ethylene glycol ingestion (unlabeled use):",
"     </b>",
"     Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of fat occlusion of central venous catheters (unlabeled use):",
"     </b>",
"     <i>",
"      Dehydrated alcohol injection:",
"     </i>",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F131119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F131120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Treatment of methanol or ethylene glycol ingestion (unlabeled use):",
"     </b>",
"     <i>",
"      Absolute ethyl alcohol:",
"     </i>",
"     Dosage adjustment for hemodialysis: Maintenance dose:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nondrinker: 169 mg/kg/hour [equivalent to 2.13 mL/kg/hour using a",
"     <b>",
"      10% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Chronic drinker: 257 mg/kg/hour [equivalent to 3.26 mL/kg/hour using a",
"     <b>",
"      10% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nondrinker: 169 mg/kg/hour [equivalent to 0.22 mL/kg/hour using a",
"     <b>",
"      98% solution",
"     </b>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Chronic drinker: 257 mg/kg/hour [equivalent to 0.33 mL/kg/hour using a",
"     <b>",
"      98% solution",
"     </b>",
"     ]",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F131096\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Aerosol, foam, topical [instant hand sanitizer]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Epi-Clenz&trade;: 70% (240 mL) [contains aloe, vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, topical [foam/instant hand sanitizer]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Epi-Clenz&trade;: 70% (480 mL) [contains aloe, vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, topical [instant hand sanitizer]: 62% (1.5 mL, 118 mL, 354 mL, 473 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Epi-Clenz&trade;: 70% (45 mL, 120 mL, 480 mL) [contains aloe, vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gel-Stat&trade;: 62% (120 mL, 480 mL) [contains aloe, vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     GelRite&trade;: 67% (120 mL, 480 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     GelRite&trade;: 67% (800 mL) [contains vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Isagel&reg;: 60% (59 mL, 118 mL, 621 mL, 800 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Prevacare&reg;: 60% (120 mL, 240 mL, 960 mL, 1200 mL, 1500 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Purell&reg;: 62% (60 mL, 360 mL, 1000 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Purell&reg;: 62% (15 mL, 30 mL, 59 mL, 60 mL, 120 mL, 236 mL, 240 mL, 250 mL, 360 mL, 500 mL, 800 mL, 1000 mL, 2000 mL) [contains moisturizers, vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Purell&reg;: 62% (15 mL, 60 mL, 360 mL, 800 mL, 1000 mL) [contains vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Purell&reg; Lasting Care: 62% (120 mL, 240 mL, 1000 mL) [contains moisturizers]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Purell&reg; Moisture Therapy: 62% (75 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Purell&reg; with Aloe: 62% (60 mL, 120 mL, 354 mL, 800 mL, 1000 mL, 2000 mL) [contains aloe, moisturizers, tartrazine, vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Purell&reg; with Aloe: 62% (15 mL, 59 mL, 236 mL) [contains aloe, tartrazine, vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [dehydrated, preservative free]: 98% (1 mL, 5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, topical [denatured]: 70% (480 mL, 3840 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, topical [denatured/rubbing alcohol]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lavacol&reg;: 70% (473 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lotion, topical [instant hand sanitizer]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Purell&reg; 2 in 1: 62% (60 mL, 360 mL, 1000 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Pad, topical [instant hand sanitizer/towelette]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Isagel&reg;: 60% (50s, 300s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Purell&reg;: 62% (24s) [contains aloe, moisturizers, tartrazine, vitamin A, vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Purell&reg;: 62% (35s, 175s) [contains moisturizers, vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, topical [instant hand sanitizer]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Protection Plus&reg;: 62% (800 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F131086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F131099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Ethylene glycol or methanol poisoning: Dilute ethyl alcohol to &le;20% solution with water or juice and administer hourly by mouth or via nasogastric tube. Out-of-hospital management with orally-administered ethanol is not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Ethylene glycol or methanol poisoning: I.V. administration via a central vein is the preferred route. Administer as a 10% solution in D",
"     <sub>",
"      5",
"     </sub>",
"     W. Initial dose should be administered over 1 hour.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Treatment of occluded central venous catheter: Instill a 70% solution with a volume equal to the internal volume of the catheter. Assess patency at 30-60 minutes (or per institutional protocol).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Intraneural: Separate needles should be used for each of multiple injections or sites to prevent residual alcohol deposition at sites not intended for tissue destruction. Inject slowly after determining proper placement of needle. Since dehydrated alcohol is hypobaric when compared with spinal fluid, proper positioning of the patient is essential to control localization of injections into the subarachnoid space.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F131098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical anti-infective; pharmaceutical aid; therapeutic neurolysis (nerve or ganglion block); replenishment of carbohydrate calories",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F131130\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antidote for ethylene glycol overdose; antidote for methanol overdose; treatment of fat occlusion of central venous catheters; septal ablation for hypertrophic obstructive cardiomyopathy (HOCM)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F131139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Ethanol may be confused with Ethyol&reg;, Ethamolin&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F131131\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Flushing, hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, CNS depression, coma, disorientation, drowsiness, encephalopathy, headache, sedation, seizure (rare), vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypoglycemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Gastric irritation, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Nerve and tissue destruction, phlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Polyuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Intoxication",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F131102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to ethyl alcohol or any component of the formulation; seizure disorder and diabetic coma; subarachnoid injection of dehydrated alcohol in patients receiving anticoagulants; pregnancy (prolonged use or high doses at term)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F131090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes mellitus; ethyl alcohol may decrease blood sugar.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gout: Use with caution in patients with gout.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Shock: Use with caution in patients with shock.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cranial surgery: Use with caution in patients following cranial surgery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infants: Minimize dermal exposure of ethyl alcohol in infants as significant systemic absorption and toxicity can occur. Ethyl alcohol passes freely into breast milk at a level approximately equivalent to maternal serum level.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pregnancy: Use with caution in pregnant women with anticipated postpartum hemorrhage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Administration: Proper positioning of the patient for neurolytic administration is essential to control localization of the injection of dehydrated alcohol (which is hypobaric) into the subarachnoid space; avoid extravasation. Not for SubQ administration. Do not administer simultaneously with blood due to the possibility of pseudoagglutination or hemolysis; may potentiate severe hypoprothrombic bleeding. Avoid extravasation during I.V. administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Monitoring: Clinical evaluation and periodic lab determinations, including serum ethanol levels, are necessary to monitor effectiveness, changes in electrolyte concentrations, and acid-base balance (when used as an antidote). Monitor blood glucose closely, particularly in children as treatment of ingestions is associated with hypoglycemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Proper storage: Flammable liquid and should be kept cool and away from any heat source.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6217619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acitretin: Alcohol (Ethyl) may enhance the teratogenic effect of Acitretin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): Alcohol (Ethyl) may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bedaquiline: Alcohol (Ethyl) may enhance the hepatotoxic effect of Bedaquiline.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bromocriptine: Alcohol (Ethyl) may enhance the adverse/toxic effect of Bromocriptine. Bromocriptine may enhance the adverse/toxic effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: Alcohol (Ethyl) may enhance the CNS depressant effect of Buprenorphine.  Management: Advise patients receiving buprenorphine about the increased risk of CNS depression if they consume alcohol.  Consider alternatives to buprenorphine for opioid addiction treatment in patients who are dependent on alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BuPROPion: Alcohol (Ethyl) may enhance the adverse/toxic effect of BuPROPion. Specifically, seizure threshold may be lowered. BuPROPion may enhance the adverse/toxic effect of Alcohol (Ethyl). Specifically, alcohol tolerance may decrease during treatment.  Management: Patients receiving bupropion should be advised to minimize or avoid alcohol consumption due to possible lower alcohol tolerance, and lower seizure threshold associated with heavy alcohol consumption/abrupt discontinuation of heavy consumption.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CefoTEtan: May enhance the adverse/toxic effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloBAZam: Alcohol (Ethyl) may enhance the CNS depressant effect of CloBAZam. Alcohol (Ethyl) may increase the serum concentration of CloBAZam.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSERINE: Alcohol (Ethyl) may enhance the neurotoxic effect of CycloSERINE. Specifically, the risk for seizures may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Didanosine: Alcohol (Ethyl) may enhance the adverse/toxic effect of Didanosine. Specifically, the risk of pancreatitis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disulfiram: May enhance the adverse/toxic effect of Alcohol (Ethyl). A disulfiram-like reaction may occur.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ethionamide: Alcohol (Ethyl) may enhance the adverse/toxic effect of Ethionamide. Specifically, there may be a risk for a psychotic episode/reaction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Alcohol (Ethyl) may enhance the CNS depressant effect of Fosphenytoin. Alcohol (Ethyl) may decrease the serum concentration of Fosphenytoin. This may be particularly applicable with chronic, heavy alcohol consumption. Alcohol (Ethyl) may increase the serum concentration of Fosphenytoin. This may be particularly applicable with acute, heavy alcohol consumption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gabapentin Enacarbil: Alcohol (Ethyl) may enhance the CNS depressant effect of Gabapentin Enacarbil. Alcohol (Ethyl) may increase the absorption of Gabapentin Enacarbil. Specifically, the rate of absorption may be enhanced, as alcohol may speed the release of drug from the extended-release tablet.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Griseofulvin: May enhance the adverse/toxic effect of Alcohol (Ethyl). A disulfiram-like reaction may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ISOtretinoin: Alcohol (Ethyl) may enhance the adverse/toxic effect of ISOtretinoin. Specifically, the risk for elevated triglyceride concentrations may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: Alcohol (Ethyl) may enhance the hepatotoxic effect of Lomitapide.  Management: Advise patients to limit alcohol consumption to 1 drink per day while receiving lomitapide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: Alcohol (Ethyl) may enhance the CNS depressant effect of Methadone.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MetroNIDAZOLE (Systemic): May enhance the adverse/toxic effect of Alcohol (Ethyl). A disulfiram-like reaction may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MetroNIDAZOLE (Topical): May enhance the adverse/toxic effect of Alcohol (Ethyl). A disulfiram-like reaction may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: Alcohol (Ethyl) may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mipomersen: Alcohol (Ethyl) may enhance the hepatotoxic effect of Mipomersen.  Management: Patients being treated with mipomersen should limit their consumption of alcohol to a maximum of 1 drink (or equivalent) per day.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: Alcohol (Ethyl) may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NIFEdipine: Alcohol (Ethyl) may increase the serum concentration of NIFEdipine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: Alcohol (Ethyl) may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of Alcohol (Ethyl). Alcohol may also worsen the negative behavioral and psychiatric effects of Perampanel.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phentermine: Alcohol (Ethyl) may enhance the adverse/toxic effect of Phentermine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Alcohol (Ethyl) may enhance the CNS depressant effect of Phenytoin. Alcohol (Ethyl) may increase the serum concentration of Phenytoin. This may be particularly applicable with acute, heavy alcohol consumption. Alcohol (Ethyl) may decrease the serum concentration of Phenytoin. This may be particularly applicable with chronic, heavy alcohol consumption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: Alcohol (Ethyl) may enhance the hypotensive effect of Phosphodiesterase 5 Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: Alcohol (Ethyl) may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propranolol: Alcohol (Ethyl) may decrease the serum concentration of Propranolol. Alcohol (Ethyl) may increase the serum concentration of Propranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: Alcohol (Ethyl) may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: Alcohol (Ethyl) may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Alcohol (Ethyl) may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.  Management: Patients receiving selective serotonin reuptake inhibitors should be advised to avoid alcohol.  Monitor for increased psychomotor impairment in patients who consume alcohol during treatment with selective serotonin reuptake inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: Alcohol (Ethyl) may enhance the adverse/toxic effect of Serotonin/Norepinephrine Reuptake Inhibitors. Specifically, risks of psychomotor impairment may be enhanced. Alcohol (Ethyl) may enhance the hepatotoxic effect of Serotonin/Norepinephrine Reuptake Inhibitors. Particularly duloxetine and milnacipran.  Management: Patients receiving serotonin/norepinephrine reuptake inhibitors (SNRIs) should be advised to avoid alcohol.  Monitor for increased psychomotor impairment and hepatotoxicity in patients who consume alcohol during treatment with SNRIs.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: Alcohol (Ethyl) may enhance the CNS depressant effect of Sodium Oxybate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sulfonylureas: May enhance the adverse/toxic effect of Alcohol (Ethyl). A flushing reaction may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the dermatologic adverse effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tapentadol: Alcohol (Ethyl) may enhance the CNS depressant effect of Tapentadol. Alcohol (Ethyl) may increase the serum concentration of Tapentadol. Specifically, alcohol may increase the maximum serum concentrations when used with extended-release tapentadol.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Alcohol (Ethyl) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tinidazole: May enhance the adverse/toxic effect of Alcohol (Ethyl). A disulfiram-like reaction may occur.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trabectedin: Alcohol (Ethyl) may enhance the hepatotoxic effect of Trabectedin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trospium: Alcohol (Ethyl) may enhance the CNS depressant effect of Trospium. Alcohol (Ethyl) may increase the serum concentration of Trospium. Specifically, alcohol may increase the peak (maximum) serum concentration of trospium when consumed within 2 hours of taking extended-release trospium.  Management: Avoid consuming any alcohol within 2 hours of taking a dose of trospium XR.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Varenicline: Alcohol (Ethyl) may enhance the adverse/toxic effect of Varenicline. Specifically, the risk for neuropsychiatric adverse effects may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Verapamil: May increase the serum concentration of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F131093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (injection) (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F131105\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted with alcohol injection. Ethanol crosses the placenta, enters the fetal circulation, and has teratogenic effects in humans. The following withdrawal symptoms have been noted in the neonate following maternal ethanol consumption during pregnancy: Crying, hyperactivity, irritability, poor suck, tremors, seizures, poor sleeping pattern, hyperphagia, and diaphoresis. Fetal alcohol syndrome (FAS) is a term referring to a combination of physical, behavioral, and cognitive abnormalities resulting from ethanol exposure during fetal development. Since a &ldquo;safe&rdquo; amount of ethanol consumption during pregnancy has not been determined, the AAP recommends those women who are pregnant or planning a pregnancy refrain from all ethanol intake. When used as an antidote during the second or third trimester, FAS is not likely to occur due to the short treatment period; use during the first trimester is controversial.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F131124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F131106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethanol is found in breast milk. Drowsiness, diaphoresis, deep sleep, weakness, decreased linear growth, and abnormal weight gain have been reported in infants following large amounts of ethanol ingestion by the mother. Ingestion &gt;1 g/kg/day decreases milk ejection reflex. The actual clearance of ethanol from breast milk is dependent upon the mother's weight and amount of ethanol consumed.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Foam",
"     </b>",
"     (DermaStat External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     65% (160 mL): $8.57",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Foam",
"     </b>",
"     (Purell Instant Hand Sanitizer External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     65% (100 mL): $2.69",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gel",
"     </b>",
"     (Antiseptic Hand Rinse External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     62% (355 mL): $5.53",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gel",
"     </b>",
"     (Isagel External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60% (2.5 g): $0.24",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60% (118 mL): $1.89",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (GelRite Hand Sanitizer External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     62% (473 mL): $5.52",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Purell Instant Hand Sanitizer External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     62% (59 mL): $1.18",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     65% (59 mL): $2.03",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Alcohol Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     98% (5 mL): $44.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Ethyl Alcohol)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100% (500 mL): $110.43",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F131094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antidotal therapy: Blood ethanol levels every 1-2 hours until steady state, then every 2-4 hours; blood glucose, electrolytes (including serum magnesium), arterial pH, blood gases, methanol or ethylene glycol blood levels; heart rate, blood pressure",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F131097\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antidote for methanol/ethylene glycol: Blood ethanol level: Goal range: 100-150 mg/dL",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F131107\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aogel (MX)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F131089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     When used to treat ethylene glycol or methanol toxicity, ethyl alcohol competitively inhibits alcohol dehydrogenase, an enzyme which catalyzes the metabolism of ethylene glycol and methanol to their toxic metabolites.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F131101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution:  V",
"     <sub>",
"      d",
"     </sub>",
"     : 0.6-0.7 L/kg; decreased in women",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic (90% to 98%) to acetaldehyde or acetate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Rate: 15-20 mg/dL/hour (range: 10-34 mg/dL/hour); increased in alcoholics",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Kidneys and lungs (~2% unchanged)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;American Academy of Pediatrics. Committee on Substance Abuse and Committee on Children With Disabilities, Fetal Alcohol Syndrome and Alcohol-Related Neurodevelopmental Disorders,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2000, 106 (2):358-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/10920168/pubmed\" id=\"10920168\" target=\"_blank\">",
"        10920168",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Barceloux DG, Krenzelok EP, Olson K, et al, &ldquo;American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Ethylene Glycol Poisoning. Ad Hoc Committee,&rdquo;",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 1999, 37(5):537-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/10497633/pubmed\" id=\"10497633\" target=\"_blank\">",
"        10497633",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Barceloux DG, Bond GR, Krenzelok EP, et al, &ldquo;American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Methanol Poisoning. Ad Hoc Committee,&rdquo;",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 2002, 40(4):415-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/12216995/pubmed\" id=\"12216995\" target=\"_blank\">",
"        12216995",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Caravati EM, Erdman AR, Christianson G, et al, &ldquo;Ethylene Glycol Exposure: An Evidence-Based Consensus Guideline for Out-of-Hospital Management,&rdquo;",
"      <i>",
"       Clin Toxicol (Phila)",
"      </i>",
"      , 2005, 43(5):327-45.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/16235508/pubmed\" id=\"16235508\" target=\"_blank\">",
"        16235508",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lepik KJ, Levy AR, Sobolev BG, et al, &ldquo;Adverse Drug Events Associated With the Antidotes for Methanol and Ethylene Glycol Poisoning: A Comparison of Ethanol and Fomepizole,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 2009, 53(4):439-450.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/18639955/pubmed\" id=\"18639955\" target=\"_blank\">",
"        18639955",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lepik KJ, Sobolev BG, Levy AR, et al, &ldquo;Medication Errors Associated With the Use of Ethanol and Fomepizole as Antidotes for Methanol and Ethylene Glycol Poisoning,&rdquo;",
"      <i>",
"       Clin Toxicol (Phila)",
"      </i>",
"      , 2011, 49(5):391-401.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Koren G, &ldquo;Drinking Alcohol While Breastfeeding. Will it Harm My Baby?&rdquo;",
"      <i>",
"       Can Fam Physician",
"      </i>",
"      , 2002, 48(5):39-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/11852608/pubmed\" id=\"11852608\" target=\"_blank\">",
"        11852608",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Maron BJ, McKenna WJ, Danielson GK, et al, &ldquo;American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2003, 42(9):1687-713.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/14607462/pubmed\" id=\"14607462\" target=\"_blank\">",
"        14607462",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Neonatal Drug Withdrawal. American Academy of Pediatrics Committee on Drugs,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1998, 101(6):1079-88.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pennington CR and Pithie AD, &ldquo;Ethanol Lock in the Management of Catheter Occlusion,&rdquo;",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 1987, 11(5):507-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/3116300/pubmed\" id=\"3116300\" target=\"_blank\">",
"        3116300",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Seggewiss H, Gleichmann U, Faber L, et al, &ldquo;Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy: Acute Results and 3-Month Follow-Up in 25 Patients,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 1998, 31(2):252-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/9462563/pubmed\" id=\"9462563\" target=\"_blank\">",
"        9462563",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sorajja P, Ommen SR, Holmes DR Jr, et al, &ldquo;Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2012, 126(20):2374-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/23076968/pubmed\" id=\"23076968\" target=\"_blank\">",
"        23076968",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Werlin SL, Lausten T, Jessens, et al, &ldquo;Treatment of Central Venous Catheter Occlusions With Ethanol and Hydrochloric Acid,&rdquo;",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 1995, 19(5):416-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/50/4904/abstract-text/8577023/pubmed\" id=\"8577023\" target=\"_blank\">",
"        8577023",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9342 Version 49.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-B2407C6BAC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4904=[""].join("\n");
var outline_f4_50_4904=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131116\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131117\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131133\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131118\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131129\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131119\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131120\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131096\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131086\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131099\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131098\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131130\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131139\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131131\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131102\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131090\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298697\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6217619\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131093\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131105\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131124\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131106\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322968\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131094\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131097\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131107\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131089\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131101\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9342\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9342|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19703?source=related_link\">",
"      Ethanol (topical and injection): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_50_4905="Emergent surgical cricothyrotomy (cricothyroidotomy)";
var content_f4_50_4905=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Emergent surgical cricothyrotomy (cricothyroidotomy)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/50/4905/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4905/contributors\">",
"     Aaron E Bair, MD, MSc, FAAEM, FACEP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/50/4905/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4905/contributors\">",
"     Allan B Wolfson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/50/4905/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4905/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/50/4905/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cricothyrotomy (also called cricothyroidotomy) is a procedure that involves placing a tube through an incision in the cricothyroid membrane to establish an airway for oxygenation and ventilation.",
"   </p>",
"   <p>",
"    The procedure has a controversial past. In 1909, Dr. Chevalier Jackson, a laryngologist at the Jefferson Medical School in Philadelphia, described the surgical techniques and critical considerations related to performing cricothyrotomy, which he called \"high tracheostomy\" [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/1\">",
"     1",
"    </a>",
"    ]. Before the advent of antibiotics, cricothyrotomy was often performed because of severe infection or an inflammatory process (eg, diphtheria). Dr. Jackson became famous for popularizing the procedure. However, he then began to receive hundreds of referrals for patients who had developed tracheal stenosis following the procedure. After investigating nearly 200 of these cases, he condemned cricothyrotomy in a well-publicized paper [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following this report, cricothyrotomy fell out of favor until the 1970s when two physicians, Brantigan and Grow, reported a series of 655 patients who had undergone elective cricothyrotomy for prolonged mechanical ventilation. They reported a low rate of complications, 6.1 percent overall [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/3\">",
"     3",
"    </a>",
"    ]. Only eight patients (0.01 percent) developed subglottic stenosis, none of whom developed a chronic condition. Consequently, cricothyrotomy, which is generally considered easier to perform than emergent tracheostomy, was revisited and has now become the surgical rescue technique of choice for the failed airway in adults.",
"   </p>",
"   <p>",
"    Because cricothyrotomy is a rarely performed but potentially life-saving procedure of last resort in the patient with a failed airway, clinicians responsible for airway management must retain familiarity with the necessary equipment and relevant anatomy. While debate continues regarding the merits and risks of various approaches or techniques for performing the procedure, it remains clear that skill acquisition and maintenance are vital. We suggest that emergency clinicians responsible for airway management review the anatomy and practice with the equipment needed for cricothyrotomy several times each year.",
"   </p>",
"   <p>",
"    Performance of cricothyrotomy in adults is reviewed here. Other aspects of difficult airway management are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18228?source=see_link\">",
"     \"The failed airway in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FREQUENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cricothyrotomy is rarely performed, but rates vary among different providers and settings. A five year review at one institution found that cricothyrotomy comprises 1 percent of all intubations in the emergency department (ED) and 10.9 percent of intubations in the prehospital setting [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/4\">",
"     4",
"    </a>",
"    ]. Earlier reports found a cricothyrotomy rate of 1.7 percent for all intubations and a rate of 14.8 percent for all prehospital intubations [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study observed a decline in the rate of cricothyrotomies performed on trauma patients over 10 years following the establishment of an emergency medicine residency training program [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/7\">",
"     7",
"    </a>",
"    ]. The cricothyrotomy rate before the residency was 1.8 percent and steadily dropped to 0.2 percent. The authors attributed the decline to several possible causes, including widespread use of rapid-sequence intubation, the presence of supervisory emergency medicine faculty 24 hours a day, and diminished concern about performing orotracheal intubation on trauma patients without first ruling out cervical spine injury by radiograph [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With ongoing adoption of advanced video laryngoscopy and increasingly effective non-invasive airway rescue techniques, it is likely that the rate of cricothyrotomy will continue to decline. However, while infrequently performed, the procedure continues to be a life-saving intervention and will likely remain the cornerstone of failed airway management for the foreseeable future. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/55/25466?source=see_link\">",
"     \"Devices for difficult emergency airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cricothyrotomy is indicated when an emergency airway is required and orotracheal or nasotracheal intubation is either unsuccessful or contraindicated. When the clinician cannot intubate and cannot oxygenate (CICO) the patient, the swift establishment of an airway is crucial. Failure to provide oxygen to the brain may lead to anoxic encephalopathy and ultimately death. In a CICO scenario, placement of an extraglottic airway device (eg, laryngeal mask airway) may be attempted as a rescue maneuver or as a bridge to provide ventilation while preparations are made to perform a cricothyrotomy. However, if oxygenation cannot be maintained, cricothyrotomy is required. Management of the difficult and failed airway is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18228?source=see_link\">",
"     \"The failed airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Conditions associated with a difficult airway that may necessitate cricothyrotomy include massive hemorrhage, profound emesis, trismus, obstructing lesions (eg, tumor, polyp), and a broad array of traumatic and congenital deformities. One study found that of all clinical conditions requiring cricothyrotomy, 32 percent involved facial fractures, 32 percent blood or vomitus in the airway, 7 percent traumatic airway obstruction, and 11 percent failed intubation in the absence of other specified problems [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS AND PRECAUTIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Absolute contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no absolute contraindications to emergency cricothyrotomy in adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Relative contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Possible or known transection of the trachea, laryngotracheal disruption with retraction of the distal trachea into the mediastinum, and fractured larynx are relative contraindications to cricothyrotomy. In such cases, tracheostomy or stabilization of the proximal tracheal segment followed by direct intubation is likely to be the best approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2026?source=see_link&amp;anchor=H13#H13\">",
"     \"Penetrating neck injuries\", section on 'Airway management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgical cricothyrotomy is relatively contraindicated in young children for several reasons. The airway of a child is funnel-shaped, with the narrowest part located at the cricoid ring rather than at the vocal cords. This narrowing increases the risk for developing subglottic stenosis following cricothyrotomy.",
"   </p>",
"   <p>",
"    Some believe that surgical cricothyrotomy can damage the cricoid cartilage of young children. Since the tracheal cartilages are C-shaped, soft, and pliable in a child, the cricoid cartilage is the only circumferential support for the trachea and thus the principal structure maintaining airway patency [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/8\">",
"     8",
"    </a>",
"    ]. A child's airway is smaller in diameter than an adult's and even a small amount of stenosis may cause significant impairment of air flow [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The preferred surgical airway technique in a young child is transtracheal ventilation using a 14 gauge needle. The age at which one can safely perform a cricothyrotomy on a child is not well established, and recommendations vary from 5 to 12 years old. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15481?source=see_link\">",
"     \"The difficult pediatric airway\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When determining whether to perform a cricothyrotomy, consider not only age, but other variables such as the child's size and physical maturity, state of health, external landmarks of the neck (eg, is the cricothyroid membrane palpable?), clinical findings, and presence of trauma.",
"   </p>",
"   <p>",
"    Surgical cricothyrotomy is relatively contraindicated in a patient with a bleeding diathesis, but in a life-threatening circumstance the need to establish an airway supersedes this concern.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PREPARATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2390688\">",
"    <span class=\"h2\">",
"     Fundamental considerations for the clinician",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once a failed airway is recognized and a cricothyrotomy is contemplated, the clinician must address a few fundamental considerations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Will a cricothyrotomy effectively bypass the airway obstruction? As an example, if the obstruction is in the distal trachea, performing a cricothyrotomy becomes a critical waste of time that will render any non-invasive ventilation technique ineffective.",
"     </li>",
"     <li>",
"      Which cricothyrotomy technique is to be used? In most cases, the emergency clinician should be familiar with the tools available in their institution to perform cricothyrotomy and should have selected and practiced a preferred technique ahead of time.",
"     </li>",
"     <li>",
"      Will the patient&rsquo;s anterior neck anatomy make the procedure particularly difficult or time consuming? If so, then plan accordingly. As an example, a percutaneous guidewire based technique (rather than an open technique) might be more appropriate in a morbidly obese patient with anatomic landmarks that are difficult to appreciate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A mnemonic for difficult cricothyrotomy is presented in the accompanying table (",
"    <a class=\"graphic graphic_table graphicRef67468 \" href=\"UTD.htm?2/49/2843\">",
"     table 1",
"    </a>",
"    ). Management of the difficult and failed airway is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18228?source=see_link\">",
"     \"The failed airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Patient counseling and informed consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;The emergent conditions under which this procedure is performed generally preclude the discussion of risks, benefits, and complications with the patient or family.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Materials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Successful performance of a cricothyrotomy depends on familiarity with the necessary equipment. Keep the cricothyrotomy equipment tray simple (",
"    <a class=\"graphic graphic_picture graphicRef62233 \" href=\"UTD.htm?25/8/25737\">",
"     picture 1",
"    </a>",
"    ), in contrast to the typical tracheostomy tray, which may contain dozens of instruments. Only a few instruments are required. Practice using the equipment several times a year so it will be familiar during an emergency.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      IV catheter &ndash; Be certain that an IV is in place and flushing easily.",
"     </li>",
"     <li>",
"      Oxygen &ndash; Administer high flow oxygen. In the setting of a failed airway, this will likely be via a bag-valve mask.",
"     </li>",
"     <li>",
"      Mechanical ventilator and tubing &ndash; Be sure the ventilator is set up and ready for use.",
"     </li>",
"     <li>",
"      Yankauer suction catheter, tubing, and canister &ndash; Check that all connections are tight and suction is adequate.",
"     </li>",
"     <li>",
"      Scalpels &ndash; Preferred sizes include numbers 11, 15, and 20 blades. Use the same blade for both the skin incision and the cricothyroid membrane incision.",
"     </li>",
"     <li>",
"      Tracheal hook &ndash; Handle the tracheal hook carefully when inserting and removing it. The hook's tip is sharp and can puncture the balloon on the tracheostomy tube causing a leak and necessitating replacement. The tip of the hook can also puncture a glove and skin.",
"     </li>",
"     <li>",
"      Tracheal dilator (Trousseau dilator) &ndash; The dilator is used to widen the opening through the cricothyroid membrane [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/10\">",
"       10",
"      </a>",
"      ]. Unlike standard scissors or needle drivers, the dilator is opened by squeezing the handles together.",
"     </li>",
"     <li>",
"      A cuffed tracheostomy tube &ndash; Note that tracheostomy tubes vary. A standard tracheostomy tube kit often includes a tube with an inner cannula as well as a solid obturator. Place the obturator in the tracheostomy tube and use it to insert the tube into the trachea. After the tube is placed, remove the obturator and replace it with the inner cannula for air exchange. In an adult a number 4 or 6 cuffed Shiley&trade; tube is used most often.",
"      <br/>",
"      <br/>",
"      Remember that a smaller diameter increases the work of breathing and is more easily obstructed by secretions. However, the cricothyroid membrane averages only 9 mm by 30 mm, so whenever possible the outer diameter of the tube should not exceed 9 mm to avoid damage to surrounding cartilage [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/11,12\">",
"       11,12",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      A number 4 Shiley&trade; tube with an inner diameter of 5 mm and an outer diameter of 9.4 mm is a good choice for most adults. However, recognize that the outer diameter of the tube is what determines whether the tube fits properly. There is significant product variability even among Shiley&trade; brand tubes.",
"     </li>",
"     <li>",
"      Alternative tube (modified endotracheal tube) &ndash; If a tracheostomy tube is not available, use a standard endotracheal tube cut to an appropriate length. To shorten the tube, remove the adaptor and cut just above the take-off of the pilot balloon tubing. Reattach the adaptor to the newly cut end and insert the tube into the trachea, as you would a tracheostomy tube. The tube can be shortened after it is inserted.",
"      <br/>",
"      <br/>",
"      Shortening the tube reduces the risk of inadvertent placement in a mainstem bronchus. Eventually, it may be helpful to replace the modified endotracheal tube with a tracheostomy tube, as the design of the tracheostomy tube makes it more stable in the airway.",
"     </li>",
"     <li>",
"      10 mL syringe &ndash; Test the balloon on the tracheostomy or endotracheal tube for leaks by injecting 10 mL of air.",
"     </li>",
"     <li>",
"      Cloth tie &ndash; The cloth tie included with the tracheostomy kit is used to secure the tube by making a circumferential tie around the neck.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     RELEVANT ANATOMY AND IDENTIFICATION OF THE CRICOTHYROID MEMBRANE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proper performance of a cricothyrotomy depends upon an understanding of the relevant anatomy and the ability to identify the cricothyroid membrane (CTM). This requires regular practice on the part of clinicians expected to perform the procedure.",
"   </p>",
"   <p>",
"    One way to improve one&rsquo;s familiarity with the anatomy is to regularly palpate the structures of the anterior neck when examining patients (",
"    <a class=\"graphic graphic_figure graphicRef86138 \" href=\"UTD.htm?13/23/13681\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef82088 \" href=\"UTD.htm?7/25/7575\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef54025 \" href=\"UTD.htm?42/36/43590\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef86096 \" href=\"UTD.htm?42/26/43432\">",
"     figure 4",
"    </a>",
"    ). Begin by palpating the laryngeal prominence, which forms the superior edge of the thyroid cartilage. There is often a prominent &ldquo;V-shaped&rdquo; notch palpable. It is often more prominent in men [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/13\">",
"     13",
"    </a>",
"    ]. The vocal cords are housed within and protected by the thyroid cartilage. The hyoid bone lies cephalad to the thyroid cartilage. In patients where the thyroid cartilage is not prominent be aware that the hyoid might be mistaken for the thyroid prominence.",
"   </p>",
"   <p>",
"    Palpate the trachea and note that it is the caudal continuation of the larynx and no longer palpable as it enters the mediastinum. The trachea is comprised in large part by a row of C-shaped cartilaginous rings that are deficient posteriorly where the trachea rests against the anterior esophagus.",
"   </p>",
"   <p>",
"    Next, identify and palpate the cricoid cartilage, which is a complete cartilaginous ring, shaped like a signet ring, with its widest part found posteriorly. It is located caudal to the thyroid cartilage. The thyroid cartilage, cricoid cartilage, and tracheal rings support and protect the airway.",
"   </p>",
"   <p>",
"    The boundaries of the cricothyroid membrane (CTM) are the thyroid cartilage superiorly, the cricoid cartilage inferiorly, and the cricothyroideus muscles laterally on both sides. Palpate the CTM. It is located about 2 cm caudal to the laryngeal prominence and can be identified by a slight depression in this area. The anatomical relationship between the thyroid and cricoid cartilages and the CTM is the most important landmark when performing cricothyrotomy.",
"   </p>",
"   <p>",
"    The cricothyroid arteries are branches of the superior thyroid arteries that course along both sides of the CTM and anastomose in the midline, closer to the superior border of the membrane. Try to avoid these arteries (this can be difficult) when performing a cricothyrotomy by incising the membrane in its inferior third.",
"   </p>",
"   <p>",
"    Some authors imply that identification of the CTM is relatively straightforward, due to its superficial location in the anterior neck. However, lack of familiarity can make it difficult to find the CTM quickly, particularly in the setting of an airway emergency. Obesity compounds this problem. Misidentification can lead clinicians to make incisions in the thyrohyoid space, which is fraught with potential complications. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Complications'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/54/20329?source=see_link\">",
"     \"Emergency airway management in the morbidly obese patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several studies highlight the potential difficulty of identifying the CTM. In one prospective observational study, anesthesiologists and obstetricians were asked to identify the CTM in 56 women patients, 15 of whom were obese [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/13\">",
"     13",
"    </a>",
"    ]. The CTM was correctly identified in 10 of 41 nonobese patients (20 percent) and 0 of 15 obese patients (0 percent). A similar study involving six patients reported that anesthesiologists correctly identified the CTM 30 percent of the time [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bedside ultrasound has been proposed as a method for identifying the CTM. Ultrasound has been used to guide tracheostomy and the results of several cadaver studies suggest that when used by experienced practitioners it is a rapid and accurate means for identifying the CTM [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. However, clinical studies of ultrasound to identify the CTM for cricothyrotomy have yet to be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PROCEDURE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Standard precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use standard precautions to protect against blood and body fluid exposure. This includes gloves, face mask, protective eyewear, gown, and shoe covers. Do not break, bend, or recap needles used in the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     General considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Place the patient in the supine position on the stretcher. Unless there is a cervical spine injury (known or suspected), extend the patient's neck to help identify the procedural landmarks and to obtain the widest exposure of the cricothyroid membrane. While assembling the equipment for the procedure, ask an assistant (preferably the respiratory therapist) to preoxygenate the patient by administering high-flow oxygen most likely via bag valve mask. Be aware that once the incision is made into the airway bag mask ventilations should be discontinued as this can insufflate the soft tissues of the neck and expel blood into the face of the operator. Either result will complicate the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Analgesia and sedation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Under emergent circumstances there may not be time to administer sedative or analgesic medications. The most important goal is to secure the airway. In the case of respiratory depression or arrest, sedation may make matters worse and is not advised. However, if the patient is agitated and struggling and this behavior is impeding the progress of the procedure, a sedative or analgesic medication can be given to help control the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Skin preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;If time permits, prepare the skin of the anterior neck with an antiseptic solution (eg, povidone-iodine). If the patient is conscious, anesthetize the skin, subcutaneous tissues, and the cricothyroid membrane with a local anesthetic such as 1 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    administered through a 27 or 30 gauge needle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monitor heart rate and rhythm, blood pressure, respiratory rate, and oxygen saturation throughout the procedure. Lower the patient's gown and sheet to observe the rise and fall of the chest with respiration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several techniques for cricothyrotomy are in common use. Performance of the Standard, Rapid Four Step, and Seldinger techniques are described here:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Standard technique",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Step 1: Immobilize the larynx and palpate the cricothyroid membrane",
"      </strong>",
"      &nbsp;(",
"      <a class=\"graphic graphic_figure graphicRef69793 \" href=\"UTD.htm?16/19/16703\">",
"       figure 5",
"      </a>",
"      ) &ndash; Stand at the patient's right side if you are right-handed, or at the patient's left side if you are left-handed. Immobilize the larynx with the nondominant hand and perform the procedure with the dominant hand.",
"      <br/>",
"      <br/>",
"      The procedure is largely tactile, so proper finger position is essential. Place the thumb and long finger of the nondominant hand on either side of the thyroid cartilage to immobilize the larynx. Palpate the laryngeal prominence at the midline of the cephalad rim of the thyroid cartilage with the index finger and then move caudally 1 to 2 cm until a small depression inferior to the thyroid cartilage is encountered. This is the cricothyroid membrane. Palpate the cricoid cartilage which is at the inferior border of the cricothyroid membrane. Maintain manual control and immobilization of the larynx throughout the procedure to preserve the anatomic relationships (ie, don't let go!).",
"      <br/>",
"      <br/>",
"      Proper stabilization and continuous palpation of the immobilized larynx serves as the foundation for the procedure, from which all other anatomic relationships are established. While immobilizing the larynx, palpate the cricothyroid membrane and complete the entire procedure by feel. Do not waste time attempting to visualize the cricothyroid membrane.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 2: Incise the skin vertically",
"      </strong>",
"      &nbsp;(",
"      <a class=\"graphic graphic_figure graphicRef82644 \" href=\"UTD.htm?30/5/30815\">",
"       figure 6",
"      </a>",
"      ) &ndash; After palpating the cricothyroid membrane, make a midline,",
"      <strong>",
"       vertical",
"      </strong>",
"      incision 3 to 5 cm long through the skin overlying the membrane. The midline skin incision avoids vascular structures located laterally. The vertical orientation allows one to extend the incision superiorly or inferiorly should the initial location be too high or too low or provide inadequate access to the cricothyroid membrane.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 3: Incise the cricothyroid membrane horizontally",
"      </strong>",
"      &nbsp;(",
"      <a class=\"graphic graphic_figure graphicRef71670 \" href=\"UTD.htm?33/33/34335\">",
"       figure 7",
"      </a>",
"      ) &ndash; Make a 1 cm",
"      <strong>",
"       horizontal",
"      </strong>",
"      incision in the cricothyroid membrane. Make the incision with care; excessive force can lead to injury of the posterior wall of the trachea. Aim the scalpel in a caudad direction to avoid the vocal cords. The cords, although surrounded by the thyroid cartilage and partially protected, are located only 0.5 to 2 cm above the cricothyroid membrane [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/9\">",
"       9",
"      </a>",
"      ]. While separating the thyroid cartilage from the cricoid cartilage, be careful not to incise or fracture either one.",
"      <br/>",
"      <br/>",
"      Once you have made the incision in the cricothyroid membrane, keep the tip of the index finger of the nondominant hand in the entry to the incision so as not to lose the opening. Continue to immobilize the larynx firmly, maintaining a triangle formed by the thumb and middle finger on opposite sides of the larynx and the index finger in the incision in the cricothyroid membrane. It is crucial not to let go at this point because there is often significant bleeding that obscures the view of the membrane.",
"      <br/>",
"      <br/>",
"      If you are unable to stabilize the larynx because of obesity, edema, trauma, aberrant anatomy, or other reasons, you may wish to leave the scalpel in the incision until you place the tracheal hook in order not to lose the opening. In this case, be careful not to injure the back wall of the trachea with the scalpel.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 4: Insert the tracheal hook",
"      </strong>",
"      &nbsp;(",
"      <a class=\"graphic graphic_figure graphicRef79117 \" href=\"UTD.htm?32/56/33679\">",
"       figure 8",
"      </a>",
"      ) &ndash; Place the tracheal hook under the thyroid cartilage and ask an assistant to provide upward traction.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 5: Insert the Trousseau dilator and open it",
"      </strong>",
"      <strong>",
"       to enlarge the incision vertically",
"      </strong>",
"      &nbsp;(",
"      <a class=\"graphic graphic_figure graphicRef68235 \" href=\"UTD.htm?41/24/42383\">",
"       figure 9",
"      </a>",
"      ) &ndash; Squeeze the handles of the dilator to open its jaws. The membrane is naturally wider in the horizontal direction, which makes the vertical direction the hardest to dilate. Overcome the resistance from the thyroid cartilage as it retracts downward and the cricoid cartilage as it retracts upward against the dilator. Leave the dilator in until the tube is placed; the thyroid and cricoid cartilages will spring back into place if the dilator is removed.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 6: Insert the tracheostomy tube",
"      </strong>",
"      &nbsp;(",
"      <a class=\"graphic graphic_figure graphicRef58528 \" href=\"UTD.htm?42/26/43426\">",
"       figure 10",
"      </a>",
"      ) &ndash; After dilating the opening, rotate the dilator 90 degrees so that the handles are pointing towards the patient's feet and insert the tube between the jaws of the Trousseau dilator. If the dilator remains in its original horizontal position, its inferior blade will prevent the tube from passing into the trachea. Once past the blades, advance the tube into the trachea. Remove the tracheal hook and Trousseau dilator. Pay particular attention not to puncture the balloon of the tube when withdrawing the sharp point of the tracheal hook.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 7: Remove the obturator",
"      </strong>",
"      (as needed, depending on type of tube used)&nbsp;(",
"      <a class=\"graphic graphic_figure graphicRef78841 \" href=\"UTD.htm?8/62/9199\">",
"       figure 11",
"      </a>",
"      ) &ndash; This is the solid object with a rounded tip.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 8: Insert the inner cannula",
"      </strong>",
"      (as needed, depending on type of tube used) and inflate the balloon&nbsp;(",
"      <a class=\"graphic graphic_figure graphicRef55500 \" href=\"UTD.htm?11/10/11439\">",
"       figure 12",
"      </a>",
"      ) - Inflate the cuff of the tube with air from a 10 mL syringe. Inflate the balloon carefully until the balloon indicator is full but not tense; overinflation increases the risk of pressure-related injury to the tracheal mucosa.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 9: Attach the tracheostomy tube to the mechanical ventilator or a bag valve device",
"      </strong>",
"      &nbsp;(",
"      <a class=\"graphic graphic_figure graphicRef57056 \" href=\"UTD.htm?17/8/17551\">",
"       figure 13",
"      </a>",
"      ) &ndash; After confirming proper placement, secure the tube with a circumferential cloth tie around the neck. Use flexible connector tubing to avoid tugging and pressure on the tracheal wall.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Rapid four step technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rapid four-step technique (RFST) can be done quickly and requires only a number 20 scalpel, hook, and cuffed tracheostomy tube [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/12\">",
"     12",
"    </a>",
"    ]. For this technique, stand at the head of the patient in the same position as when performing endotracheal intubation. Next, perform the following four steps in sequence:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Step 1:",
"      </strong>",
"      Identify the cricothyroid membrane by palpation (",
"      <a class=\"graphic graphic_figure graphicRef69793 \" href=\"UTD.htm?16/19/16703\">",
"       figure 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Step 2:",
"      </strong>",
"      Make a horizontal stab incision through both skin and cricothyroid membrane with the scalpel (",
"      <a class=\"graphic graphic_figure graphicRef72479 \" href=\"UTD.htm?33/41/34463\">",
"       figure 14",
"      </a>",
"      ). The size of the skin incision is approximately 1 to 2 cm.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 3:",
"      </strong>",
"      Prior to removal of the scalpel, the hook is placed and directed inferiorly. Caudal traction is used to stabilize the larynx (",
"      <a class=\"graphic graphic_figure graphicRef63765 \" href=\"UTD.htm?17/10/17568\">",
"       figure 15",
"      </a>",
"      ). This marks a significant change from the standard method, in which the tracheal hook is placed under the thyroid cartilage. Also in contrast with the Standard technique, this step does not require an assistant to manage the hook.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 4:",
"      </strong>",
"      Insert the tracheostomy tube into the trachea (",
"      <a class=\"graphic graphic_figure graphicRef70976 \" href=\"UTD.htm?35/54/36719\">",
"       figure 16",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The RFST can be modified by using a tracheal tube introducer (often referred to as a &ldquo;bougie&rdquo;). This is done by inserting the introducer through the incision into the trachea following step 3 above and then sliding a tracheal tube over the introducer.",
"   </p>",
"   <p>",
"    In a small randomized trial performed in anesthetized sheep by inexperienced clinicians, this modified approach increased the speed of performance (median time 67 seconds versus 149 seconds) and was considered easier to perform than the Standard technique [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Seldinger technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cricothyrotomy using a Seldinger technique has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/18\">",
"     18",
"    </a>",
"    ]. Commercial cricothyrotomy kits are available that contain all essential equipment to perform the Seldinger technique. As an example, the Cook&reg; Melker kit includes the following: a 6 mL syringe, an 18 gauge needle with overlying catheter, a guide wire, a tissue dilator, a modified airway catheter (",
"    <a class=\"graphic graphic_picture graphicRef75579 \" href=\"UTD.htm?41/29/42462\">",
"     picture 2",
"    </a>",
"    ), and tracheostomy tape. Alternatively, a tracheal tube introducer (ie, &ldquo;bougie&rdquo;) can be used to perform the technique, as described above [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Rapid four step technique'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The procedure described here is based upon the Melker kit. Perform the procedure as follows (",
"    <a class=\"graphic graphic_picture graphicRef52511 \" href=\"UTD.htm?2/1/2069\">",
"     picture 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Step 1:",
"      </strong>",
"      Be certain all equipment is present and functioning. Insert the dilator into the airway catheter. Palpate the cricothyroid membrane with the index finger of the nondominant hand while immobilizing the larynx with the thumb and middle finger (",
"      <a class=\"graphic graphic_figure graphicRef69793 \" href=\"UTD.htm?16/19/16703\">",
"       figure 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Step 2:",
"      </strong>",
"      Attach the introducer needle to the syringe, and, if time permits, fill it with a small amount of saline or water. Apply a small amount of negative pressure on the syringe and insert the needle carefully into the cricothyroid membrane at a 45 degree angle with the needle oriented caudad (",
"      <a class=\"graphic graphic_figure graphicRef75433 \" href=\"UTD.htm?14/40/14976\">",
"       figure 17",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Be careful not to insert it too far as this may damage the posterior wall of the trachea. Watch for the appearance of bubbles in the water, or feel for the free flow of air into the syringe, indicating the needle is in the airway.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 3:",
"      </strong>",
"      When bubbles appear, remove the syringe and then remove the needle, leaving the catheter in place, with its distal tip in the trachea. Thread the guidewire through the catheter into the trachea (",
"      <a class=\"graphic graphic_figure graphicRef62706 \" href=\"UTD.htm?11/39/11888\">",
"       figure 18",
"      </a>",
"      ). Remove the catheter, sliding it over the guidewire.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 4:",
"      </strong>",
"      Make a 1 to 2 cm incision in the skin at the entrance point of the guidewire with a number 15 scalpel blade. The cricothyroid membrane must also be incised at this point.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 5:",
"      </strong>",
"      Thread the combined tissue dilator-airway catheter over the guidewire and advance it into the skin incision (",
"      <a class=\"graphic graphic_figure graphicRef65251 \" href=\"UTD.htm?24/49/25360\">",
"       figure 19",
"      </a>",
"      ). Following the curve of the dilator, advance the dilator-catheter unit through the subcutaneous soft tissue and into the trachea until the cuff of the catheter is flush against the skin of the neck. A slight twisting motion may be needed.",
"     </li>",
"     <li>",
"      <strong>",
"       Step 6:",
"      </strong>",
"      Remove the tissue dilator and guidewire as a unit, leaving the airway catheter in the trachea (",
"      <a class=\"graphic graphic_figure graphicRef58139 \" href=\"UTD.htm?6/1/6160\">",
"       figure 20",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Step 7:",
"      </strong>",
"      Secure the airway catheter to the neck with the 'trach tape' provided in the kit or other appropriate means.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Time and ease of completion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The time to completion and ease of performing cricothyrotomy depend upon the surgical technique, patient, setting, and the training and experience of the clinician. Emergency clinicians must be facile with at least one approach.",
"   </p>",
"   <p>",
"    Studies of cricothyrotomy techniques are limited by the absence of randomized clinical trials. The current literature consists largely of cadaver reports and animal studies and reports disparate findings. Therefore, it is not known which technique is best in which clinical circumstance. The range of findings is suggested by the studies described here.",
"   </p>",
"   <p>",
"    Observational studies suggest that clinicians can perform cricothyrotomy reasonably quickly using the standard open technique, but that the Rapid Four Step Technique (RFST) may be faster:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An observational study reported that experienced physicians needed a median of 73 seconds (range 53 to 255 seconds), while inexperienced clinicians required a median of 180 seconds, to complete a cricothyrotomy using the standard technique in unfixed cadavers [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An observational study of 44 paramedic students found that an average of 46 seconds (range 29 to 63 seconds) were needed to complete a standard cricothyrotomy [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Studies performed on preserved human cadavers found that clinicians were 88 percent successful in performing both the standard technique and the RFST, but that the RFST was faster with a mean time of 43.2 seconds compared with 133 seconds for the standard technique [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/18\">",
"       18",
"      </a>",
"      ]. Other cadaver studies have reported the RFST to be faster [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Studies comparing cricothyrotomy using open versus the Seldinger technique report conflicting results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study of 20 emergency physicians performing cricothyrotomy on 200 human cadavers found that the time to tracheal puncture and first ventilation were significantly faster when cricothyrotomy was performed using the Seldinger technique compared to the open surgical method [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/18\">",
"       18",
"      </a>",
"      ]. Other cadaver studies have found the Seldinger approach to be effective with relatively low complication rates [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/22,23\">",
"       22,23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An observational study involving 63 medical students performing cricothyrotomy on human cadavers reported greater success, increased speed, and fewer complications among those using open versus percutaneous techniques [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Variations in technique for a given approach may affect performance. A study evaluating variations of percutaneous techniques in a pig trachea model found that a vertical incision preceding the needle placement-guidewire insertion decreased the time needed for completion of the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complication rates vary widely and depend upon the patient population, the clinical scenario, the clinician's level of training, and the location of the procedure (eg, emergency department, prehospital). Published reports cite complication rates between 0 and 54 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/4,5,18,21,26-30\">",
"     4,5,18,21,26-30",
"    </a>",
"    ]. Emergency surgical cricothyrotomy has a much higher complication rate than elective cricothyrotomy. This is likely because emergency cricothyrotomy is performed on critically ill patients with difficult airways under emergent conditions. In such cases, a higher complication rate is acceptable given the risk of death if the airway cannot be established.",
"   </p>",
"   <p>",
"    Bleeding occurs early and is not usually severe. If bleeding does occur it can usually be controlled by packing the site with gauze [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other early complications include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/4,5,26,28\">",
"     4,5,26,28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Laceration of the thyroid cartilage, cricoid cartilage, or tracheal rings",
"     </li>",
"     <li>",
"      Perforation of the posterior trachea",
"     </li>",
"     <li>",
"      Unintentional tracheostomy",
"     </li>",
"     <li>",
"      Passage of the tube into an extratracheal location (ie, false tract)",
"     </li>",
"     <li>",
"      Infection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Performance of the Rapid Four Step Technique (RFST) involves lifting the cricoid cartilage, instead of the thyroid cartilage, with the tracheal hook. The cricoid cartilage is vulnerable to injury with this technique because the tracheal hook is placed under the anterior portion where it is weakest and thinnest [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/19\">",
"     19",
"    </a>",
"    ]. However, a cadaver based study reported that the cricoid ring was able to tolerate the degree of manipulation required for intubation without cartilage fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study comparing complications of the RFST and the standard technique, the same overall rate of complications (38 percent) was observed for both, but the incidence of major complications (eg, complete transection of the cricoid cartilage, posterior tracheal or esophageal perforation) was 6 percent higher for the RFST [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/21\">",
"     21",
"    </a>",
"    ]. Other researchers studied complications rates when both techniques were performed on cadavers [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/32\">",
"     32",
"    </a>",
"    ]. They observed no complications with the standard technique but a 16.7 percent complication rate with the RFST. Four of these injuries were to the cricoid cartilage. The remaining complication was a ruptured cuff, which may be attributable to the caudal placement of the tracheal hook beside the cuff, and highlights the importance of removing the hook carefully or using a blunt hook for the RFST.",
"   </p>",
"   <p>",
"    Long-term complications include subglottic stenosis and voice changes. Subglottic stenosis has been associated with prolonged intubation, underlying laryngeal disease, and younger age [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is limited data regarding the safety of cricothyrotomy in patients with known or suspected cervical spine injury. A study using a cadaver model of an unstable injury at the level of the fifth cervical vertebra observed 1 to 2 mm of anterior-posterior (AP) displacement and less than 1 mm of axial compression by fluoroscopy during the performance of a standard open cricothyrotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/34\">",
"     34",
"    </a>",
"    ]. The amount of movement considered safe is undetermined, making interpretation of these results difficult. Studies report a low risk of neurologic deterioration with less than 3 mm of AP displacement [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4905/abstract/35-38\">",
"     35-38",
"    </a>",
"    ]. No case of neurologic deterioration or exacerbation of injury has been reported following cricothyrotomy in trauma patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     FOLLOW-UP CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate ventilator settings are made for the patient. Adequate sedation and analgesia should be provided as needed. Follow-up care for the tracheostomy tube is provided by the admitting service in consultation with surgery or otolaryngology as the case dictates. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/25/6554?source=see_link\">",
"     \"Mechanical ventilation of adults in the emergency department\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H341222240\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Emergency cricothyrotomy (or cricothyroidotomy) is a rarely performed but potentially life-saving procedure of last resort in the patient with a failed airway. We suggest that emergency clinicians responsible for airway management review the anatomy, choose a preferred technique, and practice with the equipment needed for cricothyrotomy several times per year.",
"     </li>",
"     <li>",
"      Cricothyrotomy is indicated when an emergency airway is required and orotracheal or nasotracheal intubation is either unsuccessful or contraindicated. Relative contraindications include complete transection of the trachea and laryngotracheal disruption with retraction of the distal trachea into the mediastinum. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Indications'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Contraindications and precautions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The equipment necessary for cricothyrotomy is described in the text. The cricothyrotomy equipment tray should be kept simple (",
"      <a class=\"graphic graphic_picture graphicRef62233 \" href=\"UTD.htm?25/8/25737\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Materials'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Emergent cricothyrotomy is largely a tactile procedure; the field can become bloody following the initial incision, obscuring the view of any landmarks. Clinicians must be familiar with the relevant anatomy (",
"      <a class=\"graphic graphic_figure graphicRef86138 \" href=\"UTD.htm?13/23/13681\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef82088 \" href=\"UTD.htm?7/25/7575\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Relevant anatomy and identification of the cricothyroid membrane'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Three primary methods for performing emergent cricothyrotomy have been described: Standard, Rapid Four Step, and Seldinger. Each is described in the text. No one method has been proven to be superior. Clinicians should choose at least one method in which to become proficient. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Procedure'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/1\">",
"      Jackson, C.  Tracheotomy. Laryngoscope 1909; 18:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/2\">",
"      Jackson, C. High tracheotomy and other errors the chief cause of chronic laryngeal stenosis. Surg Gyneco Obstet 1921; 32:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/3\">",
"      Brantigan CO, Grow JB Sr. Cricothyroidotomy: elective use in respiratory problems requiring tracheotomy. J Thorac Cardiovasc Surg 1976; 71:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/4\">",
"      Bair AE, Panacek EA, Wisner DH, et al. Cricothyrotomy: a 5-year experience at one institution. J Emerg Med 2003; 24:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/5\">",
"      Erlandson MJ, Clinton JE, Ruiz E, Cohen J. Cricothyrotomy in the emergency department revisited. J Emerg Med 1989; 7:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/6\">",
"      Fortune JB, Judkins DG, Scanzaroli D, et al. Efficacy of prehospital surgical cricothyrotomy in trauma patients. J Trauma 1997; 42:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/7\">",
"      Chang RS, Hamilton RJ, Carter WA. Declining rate of cricothyrotomy in trauma patients with an emergency medicine residency: implications for skills training. Acad Emerg Med 1998; 5:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/8\">",
"      Scrase I, Woollard M. Needle vs surgical cricothyroidotomy: a short cut to effective ventilation. Anaesthesia 2006; 61:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/9\">",
"      Schroeder AA. Cricothyroidotomy: when, why, and why not? Am J Otolaryngol 2000; 21:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/10\">",
"      Bramwell KJ, Davis DP, Cardall TV, et al. Use of the Trousseau dilator in cricothyrotomy. J Emerg Med 1999; 17:433.",
"     </a>",
"    </li>",
"    <li>",
"     Strange, GR, Niederman, LG. Surgical Cricothyrotomy. In: Textbook of Pediatric Emergency Procedures, Henretic, FM, King, C (Eds), Williams and Wilkens, Baltimore 1997. p.351.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/12\">",
"      Salvino CK, Dries D, Gamelli R, et al. Emergency cricothyroidotomy in trauma victims. J Trauma 1993; 34:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/13\">",
"      Aslani A, Ng SC, Hurley M, et al. Accuracy of identification of the cricothyroid membrane in female subjects using palpation: an observational study. Anesth Analg 2012; 114:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/14\">",
"      Elliott DS, Baker PA, Scott MR, et al. Accuracy of surface landmark identification for cannula cricothyroidotomy. Anaesthesia 2010; 65:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/15\">",
"      Nicholls SE, Sweeney TW, Ferre RM, Strout TD. Bedside sonography by emergency physicians for the rapid identification of landmarks relevant to cricothyrotomy. Am J Emerg Med 2008; 26:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/16\">",
"      Curtis K, Ahern M, Dawson M, Mallin M. Ultrasound-guided, Bougie-assisted cricothyroidotomy: a description of a novel technique in cadaveric models. Acad Emerg Med 2012; 19:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/17\">",
"      Hill C, Reardon R, Joing S, et al. Cricothyrotomy technique using gum elastic bougie is faster than standard technique: a study of emergency medicine residents and medical students in an animal lab. Acad Emerg Med 2010; 17:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/18\">",
"      Schaumann N, Lorenz V, Schellongowski P, et al. Evaluation of Seldinger technique emergency cricothyroidotomy versus standard surgical cricothyroidotomy in 200 cadavers. Anesthesiology 2005; 102:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/19\">",
"      Mutzbauer TS, Munz R, Helm M, et al. [Emergency cricothyrotomy--puncture or anatomical preparation? Peculiarities of two methods for emergency airway access demonstrated in a cadaver model]. Anaesthesist 2003; 52:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/20\">",
"      Brofeldt BT, Panacek EA, Richards JR. An easy cricothyrotomy approach: the rapid four-step technique. Acad Emerg Med 1996; 3:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/21\">",
"      Holmes JF, Panacek EA, Sakles JC, Brofeldt BT. Comparison of 2 cricothyrotomy techniques: standard method versus rapid 4-step technique. Ann Emerg Med 1998; 32:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/22\">",
"      Benkhadra M, Lenfant F, Nemetz W, et al. A comparison of two emergency cricothyroidotomy kits in human cadavers. Anesth Analg 2008; 106:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/23\">",
"      Chan TC, Vilke GM, Bramwell KJ, et al. Comparison of wire-guided cricothyrotomy versus standard surgical cricothyrotomy technique. J Emerg Med 1999; 17:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/24\">",
"      Schober P, Hegemann MC, Schwarte LA, et al. Emergency cricothyrotomy-a comparative study of different techniques in human cadavers. Resuscitation 2009; 80:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/25\">",
"      Kanji H, Thirsk W, Dong S, et al. Emergency cricothyroidotomy: a randomized crossover trial comparing percutaneous techniques: classic needle first versus \"incision first\". Acad Emerg Med 2012; 19:E1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/26\">",
"      McGill J, Clinton JE, Ruiz E. Cricothyrotomy in the emergency department. Ann Emerg Med 1982; 11:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/27\">",
"      Johnson DR, Dunlap A, McFeeley P, et al. Cricothyrotomy performed by prehospital personnel: a comparison of two techniques in a human cadaver model. Am J Emerg Med 1993; 11:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/28\">",
"      Gillespie MB, Eisele DW. Outcomes of emergency surgical airway procedures in a hospital-wide setting. Laryngoscope 1999; 109:1766.",
"     </a>",
"    </li>",
"    <li>",
"     Mace, SE, Hedges, JR. Cricothyrotomy and Translaryngeal Jet Ventilation. In: Clinical Procedures in Emergency Medicine, 4th ed, Roberts, JR, Hedges, JR, Chanmugam, AS, et al (Eds), Saunders, Philadelphia 2004. p.115.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/30\">",
"      Eisenburger P, Laczika K, List M, et al. Comparison of conventional surgical versus Seldinger technique emergency cricothyrotomy performed by inexperienced clinicians. Anesthesiology 2000; 92:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/31\">",
"      Bair AE, Laurin EG, Karchin A, et al. Cricoid ring integrity: implications for cricothyrotomy. Ann Emerg Med 2003; 41:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/32\">",
"      Davis DP, Bramwell KJ, Vilke GM, et al. Cricothyrotomy technique: standard versus the Rapid Four-Step Technique. J Emerg Med 1999; 17:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/33\">",
"      Spaite DW, Joseph M. Prehospital cricothyrotomy: an investigation of indications, technique, complications, and patient outcome. Ann Emerg Med 1990; 19:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/34\">",
"      Gerling MC, Davis DP, Hamilton RS, et al. Effect of surgical cricothyrotomy on the unstable cervical spine in a cadaver model of intubation. J Emerg Med 2001; 20:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/35\">",
"      Curran C, Dietrich AM, Bowman MJ, et al. Pediatric cervical-spine immobilization: achieving neutral position? J Trauma 1995; 39:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/36\">",
"      Intsuka IKh. [Correlation between the neurologic and x-ray data in fracture-dislocation of the cervical vertebrae]. Vopr Neirokhir 1972; 36:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/37\">",
"      Horlyck E, Rahbek M. Cervical spine injuries. Acta Orthop Scand 1974; 45:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4905/abstract/38\">",
"      Barnes, R. Paraplegia in cervical spine injuries. J Bone Joint Surg 1948; 30:234.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 263 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-02DD474397-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4905=[""].join("\n");
var outline_f4_50_4905=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H341222240\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FREQUENCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CONTRAINDICATIONS AND PRECAUTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Absolute contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Relative contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2390688\">",
"      Fundamental considerations for the clinician",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Patient counseling and informed consent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Materials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      RELEVANT ANATOMY AND IDENTIFICATION OF THE CRICOTHYROID MEMBRANE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Standard precautions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      General considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Analgesia and sedation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Skin preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Standard technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Rapid four step technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Seldinger technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Time and ease of completion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      FOLLOW-UP CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H341222240\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/263\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/263|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/23/13681\" title=\"figure 1\">",
"      Anatomic landmarks for emergency cricothyrotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/25/7575\" title=\"figure 2\">",
"      Anatomy of the cricothyroid membrane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/36/43590\" title=\"figure 3\">",
"      Cross section head neck",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/26/43432\" title=\"figure 4\">",
"      Anterior neck anatomy dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/19/16703\" title=\"figure 5\">",
"      Standard cricothyrotomy step one",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/5/30815\" title=\"figure 6\">",
"      Standard cricothyrotomy step two",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/33/34335\" title=\"figure 7\">",
"      Standard cricothyrotomy step three",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/56/33679\" title=\"figure 8\">",
"      Standard cricothyrotomy step four",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/24/42383\" title=\"figure 9\">",
"      Standard cricothyrotomy step five",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/26/43426\" title=\"figure 10\">",
"      Standard cricothyrotomy step six",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/62/9199\" title=\"figure 11\">",
"      Standard cricothyrotomy step seven",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/10/11439\" title=\"figure 12\">",
"      Standard cricothyrotomy step eight",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/8/17551\" title=\"figure 13\">",
"      Standard cricothyrotomy step nine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/41/34463\" title=\"figure 14\">",
"      Rapid cricothyrotomy step two",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/10/17568\" title=\"figure 15\">",
"      Rapid cricothyrotomy step three",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/54/36719\" title=\"figure 16\">",
"      Rapid cricothyrotomy step four",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/40/14976\" title=\"figure 17\">",
"      Seldinger cricothyrotomy step 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/39/11888\" title=\"figure 18\">",
"      Seldinger cricothyrotomy step 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/49/25360\" title=\"figure 19\">",
"      Seldinger cricothyrotomy step 5",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/1/6160\" title=\"figure 20\">",
"      Seldinger cricothyrotomy step 6",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/263|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/8/25737\" title=\"picture 1\">",
"      Cricothyroidotomy equipment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/29/42462\" title=\"picture 2\">",
"      Melker cricothyrotomy catheter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/1/2069\" title=\"picture 3\">",
"      Seldinger technique for cricothyroidotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/263|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/49/2843\" title=\"table 1\">",
"      SMART mnemonic for difficult cricothyrotomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/55/25466?source=related_link\">",
"      Devices for difficult emergency airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/54/20329?source=related_link\">",
"      Emergency airway management in the morbidly obese patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/25/6554?source=related_link\">",
"      Mechanical ventilation of adults in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2026?source=related_link\">",
"      Penetrating neck injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=related_link\">",
"      Rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=related_link\">",
"      The difficult airway in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15481?source=related_link\">",
"      The difficult pediatric airway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18228?source=related_link\">",
"      The failed airway in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_50_4906="Surgical management of ulcerative colitis";
var content_f4_50_4906=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical management of ulcerative colitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/50/4906/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4906/contributors\">",
"     Jacques Heppell, MD, FRCSC, FASCRS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/50/4906/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4906/contributors\">",
"     Martin Weiser, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4906/contributors\">",
"     Paul Rutgeerts, MD, PhD, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/50/4906/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/50/4906/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/50/4906/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical therapy is central to the management of inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn&rsquo;s disease. However, surgical management is an important component of therapy since it alleviates symptoms, addresses serious complications, improves quality of life, and, in some settings, is lifesaving [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will address surgical management of patients with ulcerative colitis. Medical management of ulcerative colitis and operative and medical management of Crohn&rsquo;s disease are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3319?source=see_link\">",
"     \"Management of severe ulcerative colitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/29/38361?source=see_link\">",
"     \"Operative management of Crohn's disease of the small bowel and colon\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19305?source=see_link\">",
"     \"Overview of the medical management of mild to moderate Crohn's disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DISTINGUISHING BETWEEN ULCERATIVE COLITIS AND CROHN'S DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical management decisions and postoperative outcomes from surgical management of inflammatory bowel disease are influenced by the underlying diagnosis of ulcerative colitis versus Crohn's disease [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients with ulcerative colitis are eligible for sphincter preserving operations.",
"     </li>",
"     <li>",
"      Segmental resections are sometimes performed for limited areas of Crohn's colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/4\">",
"       4",
"      </a>",
"      ], but are inappropriate for patients with ulcerative colitis because of the risk of recurrent active inflammation or cancer developing in the remaining colon.",
"     </li>",
"     <li>",
"      Restorative proctocolectomy with an ileal pouch-anal canal anastomosis, typically performed for patients with ulcerative colitis, is infrequently performed for patients with Crohn's disease because of poorer functional outcomes and a higher failure rate [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ulcerative colitis and Crohn's colitis can usually be distinguished based upon clinical presentation, radiography, endoscopy (eg, continuous colitis in ulcerative colitis compared with patchy involvement in Crohn's disease), and biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11386?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20490?source=see_link\">",
"     \"Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, colitis is indeterminate in 8 to 20 percent of patients; the distinction may be particularly difficult in patients with fulminant colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/6\">",
"     6",
"    </a>",
"    ]. The course of these patients tends to resemble that of patients with ulcerative colitis more than it does Crohn's disease, although there may be an increased risk of perineal complications and pouch failure [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Thus, many surgeons consider patients with indeterminate colitis to be candidates for the same surgical options as those with ulcerative colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/1,9\">",
"     1,9",
"    </a>",
"    ], although some, in the presence of rectal sparing, prefer ileoproctostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/10\">",
"     10",
"    </a>",
"    ]. In a proportion of patients with colitis who do not require surgery, it can also be difficult to distinguish between ulcerative colitis and Crohn&rsquo;s disease. The term inflammatory bowel disease unclassified is proposed for these cases. Further evaluation may reveal the exact type of disease in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following studies illustrate the clinical differences identified in the postoperative period for patients with a delayed diagnosis of Crohn&rsquo;s disease: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In a review of 2814 patients who underwent ileal pouch anal anastomosis for ulcerative colitis or indeterminate colitis, 184 patients (7 percent) had the diagnosis revised to Crohn&rsquo;s disease; the diagnosis was revised in the immediate postoperative period in 97 patients (53 percent) and within 36 months in 87 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/12\">",
"       12",
"      </a>",
"      ]. Patients with a delayed diagnosis of Crohn&rsquo;s disease were significantly more likely to have a perianal fistula compared with those with a final diagnosis of ulcerative",
"      <span class=\"nowrap\">",
"       colitis/indeterminate",
"      </span>",
"      colitis (6 of 87 versus 56 of 2630 patients). In addition, patients with a delayed diagnosis of Crohn&rsquo;s disease were significantly more likely to have a colorectal stricture (5 of 87 versus 44 of 2630 patients), mouth ulceration (5 of 87 versus 40 of 2630 patients), female gender (47 of 87 versus 1118 of 2630 patients), and diagnosis at a younger median age (29.5 versus 38.0 years).",
"     </li>",
"     <li>",
"      In a series of 70 children who underwent total colectomy for a clinical diagnosis of ulcerative colitis (90 percent) or intermediate colitis (10 percent), 10 patients (14.3 percent) had a delayed diagnosis of Crohn&rsquo;s disease [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/13\">",
"       13",
"      </a>",
"      ]. Nine of the patients with Crohn&rsquo;s disease had undergone restorative pouch reconstruction and seven patients developed complications, including anastomotic strictures, perianal fistulas, and perianal abscesses.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR OPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in medical therapy, including use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    , have reduced catastrophic complications such as massive hemorrhage, perforation, fulminant colitis, and acute colonic obstruction as well as the need for an emergent total colectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/4/44105?source=see_link\">",
"     \"Infliximab in Crohn's disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/30/18920?source=see_link\">",
"     \"Toxic megacolon\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is estimated that approximately 20 to 30 percent of patients with ulcerative colitis will eventually require a surgical resection [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. The development of continence-preserving procedures such as the ileal pouch-anal anastomosis has made surgery a more attractive option in patients for whom medical therapy has been unsuccessful in controlling symptoms or is undesirable. Restorative proctocolectomy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/13/25818?source=see_link\">",
"     \"Restorative proctocolectomy with ileal pouch-anal anastomosis: Laparoscopic approach\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of choice for acute severe steroid refractory ulcerative colitis is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/18\">",
"     18",
"    </a>",
"    ]. Gastroenterologists advocate a trial of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/19\">",
"     19",
"    </a>",
"    ], while surgeons favor total colectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/20\">",
"     20",
"    </a>",
"    ], since a longer duration of in-hospital ineffective medical therapy that delays surgical therapy in patients with acute severe ulcerative colitis increases the risk of complications [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/21\">",
"     21",
"    </a>",
"    ]. A range of 15 to 50 percent of patients in an emergent clinical setting will require operative intervention during that admission; life-saving operative management should not be delayed in the hope of preserving the colon [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/22\">",
"     22",
"    </a>",
"    ]. Medical management of severe ulcerative colitis is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3319?source=see_link\">",
"     \"Management of severe ulcerative colitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6558011\">",
"    <span class=\"h2\">",
"     Emergent clinical settings",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6558083\">",
"    <span class=\"h3\">",
"     Acute fulminant colitis with acute abdomen",
"    </span>",
"    &nbsp;&mdash;&nbsp;An acute abdomen in patients with acute fulminant colitis is",
"    <strong>",
"    </strong>",
"    a potentially life-threatening condition and, therefore, an absolute indication for immediate surgical treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/23\">",
"     23",
"    </a>",
"    ]. An acute abdomen in this setting can be caused by toxic megacolon, perforation, or hemorrhage. Toxic megacolon, which may be triggered by the administration of narcotic, antidiarrheal, anticholinergic and antidepressant medication, occurs in approximately 5 to 10 percent of patients with acute fulminant colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/30/18920?source=see_link\">",
"     \"Toxic megacolon\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Increasing colonic dilatation with thumbprinting (edema of the colonic wall) or pneumatosis (air dissecting the bowel wall) indicates impending perforation and the need for emergency surgery. Free perforation is rare and usually represents the end result of an untreated toxic megacolon. Free abdominal air occasionally can be detected on abdominal percussion in the loss of the hepatic dullness, or can be visible by an upright chest x-ray with demonstration of air beneath the diaphragm. A walled-off perforation is slightly more common. This complication usually manifests itself with persistent localized tenderness, fever, and an elevated white cell count. The frequency of severe hemorrhage ranges from 0 to 4.5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1203357\">",
"    <span class=\"h2\">",
"     Urgent clinical settings",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1203394\">",
"    <span class=\"h3\">",
"     Acute fulminant colitis without acute abdomen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typically, patients with acute fulminant colitis without an acute abdomen have unremitting bloody diarrhea, abdominal pain, and occasionally tenesmus [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/17\">",
"     17",
"    </a>",
"    ]. Because of the rapidity with which the clinical situation may deteriorate, they should be treated and monitored in a hospital environment to determine the optimal treatment and the timing for surgical intervention if it becomes necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3319?source=see_link\">",
"     \"Management of severe ulcerative colitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6558357\">",
"    <span class=\"h2\">",
"     Elective clinical settings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical settings that warrant strong consideration of a total colectomy in an elective setting include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H165136371\">",
"    <span class=\"h3\">",
"     Risk reduction for colon and rectal cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the clinical setting of no detectable precancerous lesions, a prophylactic total colectomy is an option for patients with long-standing ulcerative colitis. The risk of developing colon or rectal cancer during the first 8 to 10 years after a diagnosis of colitis is low, but the risk of developing cancer steadily increases with an incidence of 0.5 to 1 percent per year after the first decade of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/29\">",
"     29",
"    </a>",
"    ]. The extent of colitis (ie, pancolitis versus left sided colitis) but not the severity of colitis does not appear to increase the cancer risk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/7/25722?source=see_link\">",
"     \"Colorectal cancer surveillance in inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3875966\">",
"    <span class=\"h3\">",
"     Precancerous lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with precancerous lesions such as dysplastic lesions and tubular or villous adenomas of the colon should be offered a proctocolectomy to prevent the development of a malignancy.",
"   </p>",
"   <p>",
"    Cancer risk in the presence of a low-grade dysplasia is approximately 10 to 30 percent, for high-grade dysplasia the risk is 30 to 40 percent, and when dysplasia is associated with a lesion or mass (DALM), the risk of concomitant carcinoma approximates 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. If a proctocolectomy is not acceptable to patients with low grade dysplasia, biopsies should be repeated within four to six months to monitor the progress of the dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. While polypectomy may be safe for sporadic adenomas in patients with ulcerative colitis, a 13 percent five-year cumulative incidence of subsequent neoplasia mandates a strict surveillance schedule [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/7/25722?source=see_link&amp;anchor=H19#H19\">",
"     \"Colorectal cancer surveillance in inflammatory bowel disease\", section on 'Surveillance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6557946\">",
"    <span class=\"h3\">",
"     Intractable disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common indication for elective surgery is disease activity that has been intractable to medical therapy. However, \"intractable\" is often hard to define. Some authorities have suggested that disease should be considered intractable when it or its treatment is associated with severe and persistent impairment in the quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/1,26-28,35\">",
"     1,26-28,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following clinical settings are examples of parameters, although difficult to measure and variable among individual patients, that are used to determine if the disease is intractable:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent symptoms despite high-dose corticosteroid therapy",
"     </li>",
"     <li>",
"      Dependence upon steroids to maintain remission",
"     </li>",
"     <li>",
"      Progression of disease with worsening of the symptoms or new onset of complications while on maximal medical therapy",
"     </li>",
"     <li>",
"      Significant treatment-related complications such as severe steroid side effects (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"       \"Major side effects of systemic glucocorticoids\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The threshold for performing surgery may be lowered by a number of other factors such as the presence of anemia or hypoproteinemia, and growth restriction in children. On the other hand, the threshold may be increased in patients with severe comorbid illnesses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2171787\">",
"    <span class=\"h3\">",
"     Indeterminate colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In approximately 10 to 15 percent of patients with inflammatory bowel disease, the distinction between Crohn&rsquo;s disease and ulcerative colitis cannot be made; such patients are referred to as having indeterminate colitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20490?source=see_link&amp;anchor=H12689134#H12689134\">",
"     \"Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults\", section on 'Ulcerative colitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indeterminate colitis is identified in two clinical settings [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute fulminant colitis in patients who may require a colectomy during the first presentation of their disease before a definitive diagnosis is confirmed.",
"     </li>",
"     <li>",
"      Uncertainty of diagnosis despite repeated physical, endoscopic, radiologic, and pathologic examinations. Prolonged observation and repeat diagnostic studies eventually clarify the diagnosis in all except a few patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While the indications for acute surgical management of indeterminate colitis are the same as for patients with ulcerative or Crohn's colitis, the initial procedure should be a total abdominal colectomy with ileostomy and Hartmann procedure or mucous fistula. A restorative proctectomy with ileal anal pouch anastomosis is an option for patients with the definitive pathologic diagnosis of ulcerative colitis, but typically not for patients with Crohn&rsquo;s colitis. This approach is followed because patients with indeterminate colitis who do not develop signs or symptoms of Crohn's disease experience long-term functional outcomes nearly identical to patients with chronic ulcerative colitis, while long-term outcomes for patients with Crohn&rsquo;s disease are usually poor [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/13/25818?source=see_link\">",
"     \"Restorative proctocolectomy with ileal pouch-anal anastomosis: Laparoscopic approach\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/29/38361?source=see_link\">",
"     \"Operative management of Crohn's disease of the small bowel and colon\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Extraintestinal manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ulcerative colitis is frequently associated with extraintestinal disease and complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11386?source=see_link&amp;anchor=H1844647817#H1844647817\">",
"     \"Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults\", section on 'Extraintestinal manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The response of extracolonic manifestations of ulcerative colitis to colectomy is not well defined and clinical improvement in extraintestinal manifestations following a total colectomy is variable. For example, patients with life threatening thromboembolic complications, erythema nodosum, massive hemolytic anemia (including a splenectomy), and arthralgia of the small and large joints appear to benefit the most from proctocolectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/1,36,37\">",
"     1,36,37",
"    </a>",
"    ]. However, patients with pyoderma gangrenosum or ankylosing spondylitis and arthritis may not regress after a total colectomy. Progression of sclerosing cholangitis does not appear to be associated with the presence or absence of the inflammatory process in the colon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H165136853\">",
"    <span class=\"h1\">",
"     TYPES OF SURGICAL PROCEDURES BASED UPON CLINICAL SETTING",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96428458\">",
"    <span class=\"h2\">",
"     Acute setting procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;A total abdominal colectomy is the operation of choice for management of acute fulminant ulcerative colitis with or without toxic megacolon. Typically, in emergent and urgent clinical settings, the rectum is not resected but is managed as a mucous fistula or Hartmann procedure. A temporary ileostomy is constructed. The completion proctectomy or ileal pouch-anal anastomosis is performed electively. In a series of 50 patients with fulminant colitis, a staged minimally invasive subtotal colectomy followed by minimally invasive completion proctectomy with ileal pouch-anal anastomosis appeared to be feasible, safe, and a reasonable operative strategy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/13/25818?source=see_link&amp;anchor=H7533288#H7533288\">",
"     \"Restorative proctocolectomy with ileal pouch-anal anastomosis: Laparoscopic approach\", section on 'Patient selection criteria for laparoscopic RPC-IPAA'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/12/28873?source=see_link\">",
"     \"Surgical principles of ostomy construction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Elective setting procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are five surgical procedures, performed in single or multiple stages, that can be offered to patients with ulcerative colitis who are referred for elective colectomy (",
"    <a class=\"graphic graphic_table graphicRef56142 \" href=\"UTD.htm?6/62/7148\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef52597 \" href=\"UTD.htm?19/49/20247\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Proctocolectomy with permanent ileostomy (Brooke ileostomy)",
"     </li>",
"     <li>",
"      Proctocolectomy with continent ileostomy (Kock pouch)",
"     </li>",
"     <li>",
"      Abdominal colectomy with ileorectal anastomosis",
"     </li>",
"     <li>",
"      Total colectomy, mucosal proctectomy (restorative proctocolectomy) and ileal pouch-anal anastomosis (RPC-IPAA) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/13/25818?source=see_link\">",
"       \"Restorative proctocolectomy with ileal pouch-anal anastomosis: Laparoscopic approach\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Total colectomy and stapled ileal pouch distal rectal anastomosis (IPDRA)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Each technique can improve the quality of life and reduce the risk of colonic malignancy, and each has its advantages and disadvantages [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Optimal results depend upon surgical expertise, the clinical setting, and careful patient selection. The patient's age, previous intestinal or anal surgery, previous vaginal deliveries or history of anal incontinence, obesity, patient occupation, liver disease, and cancer risk should all be considered.",
"   </p>",
"   <p>",
"    A number of specific surgical issues remain controversial, including the merits of avoiding a loop diverting ileostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/41,42\">",
"     41,42",
"    </a>",
"    ], the safety and efficacy of laparoscopic approaches [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/43-46\">",
"     43-46",
"    </a>",
"    ], and complications associated with coexisting manifestations of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/47\">",
"     47",
"    </a>",
"    ]. For example, one study showed that, compared with the open procedures, laparoscopic assisted restorative proctocolectomy had a long-lasting positive impact on body image and cosmesis, particularly for women [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/48\">",
"     48",
"    </a>",
"    ]. Technical advances have allowed skilled laparoscopists to perform single&ndash;port [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/49-51\">",
"     49-51",
"    </a>",
"    ] and robotic assisted [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/52\">",
"     52",
"    </a>",
"    ] proctocolectomy with IPAA. The laparoscopic approach is associated with significantly fewer incisional, abdominal, and pelvic adhesions [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. In addition, complications from surgical management of patients with coexisting primary sclerosing cholangitis appear mostly to be related to the severity of the liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In emergent situations (such as toxic megacolon), abdominal colectomy with ileostomy and closure of the rectum or mucous fistula is the procedure of choice. Leaving the rectum in place permits subsequent proctectomy with ileal pouch-anal anastomosis (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/30/18920?source=see_link\">",
"     \"Toxic megacolon\"",
"    </a>",
"    ). Emergency proctocolectomy may also be required for uncontrollable hemorrhage. However, anal suturing of a bleeding rectal ulcer or leaving a short Hartmann pouch can also be considered in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/55\">",
"     55",
"    </a>",
"    ]. IPAA should not be performed on patients with toxic colitis due to excessively high complication rates. In addition, patients who are on combination immunosuppressive therapy that includes",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"     Infliximab",
"    </a>",
"    may benefit from a three-stage IPAA [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A total proctocolectomy with permanent ileostomy is curative for ulcerative colitis, and can be performed laparoscopically as a &ldquo;scarless&rdquo; or &ldquo;incisionless&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/57,58\">",
"     57,58",
"    </a>",
"    ] procedure. Patients should be advised that an ileostomy will be required if a continence preserving procedure fails (eg, restorative proctocolectomy) or is not technically or physiologically (eg, anal sphincter function is not intact) possible. Furthermore, continence preserving procedures are associated with a small risk of urinary and sexual dysfunction; the risk is greatest in patients who require reoperative pelvic surgery. Postoperative impotence and retrograde ejaculation are observed in approximately 1.5 and 4 percent of men, respectively, while transient dyspareunia occurs in about 7 percent of women. Decreased fertility is also frequent in women after IPAA.",
"   </p>",
"   <p>",
"    The surgeon is occasionally faced with the need to abandon the ileal pouch-anal canal anastomosis intraoperatively because of technical reasons or evidence of Crohn's disease or cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. In a review of almost 1800 IPAA attempts from the Mayo Clinic, abandonment was required in 4.1 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The stapled ileal pouch-distal rectal anastomosis is technically easier to perform than the ileal pouch-anal canal anastomosis and, in theory, preservation of the anal transitional mucosa should maintain anal sensation and better continence, especially at night. However, this operation leaves diseased anal and distal rectal mucosa behind. Preservation of the distal rectal mucosa should clearly be avoided in patients with cancer or severe dysplasia in the colorectal mucosa, and in those with severe extraintestinal manifestations. On the other hand, it should be strongly considered in older patients, and in those in whom mobilization of the pouch to perform a tension-free anastomosis is difficult.",
"   </p>",
"   <p>",
"    At our institution, an ileorectal anastomosis (IRA) has been used in fewer than 10 percent of patients undergoing surgery for ulcerative colitis, even in the era when ileal pouch-anal anastomosis (IPAA) was not available, because the IRA procedure does not excise the diseased section and, thus, leaves patients at risk for persistence of symptoms and future malignancy. A retrospective analysis of the functional results after IRA for ulcerative colitis or indeterminant colitis in 86 patients found that the rectum was eventually resected in 46 patients diagnosed with rectal dysplasia (17 percent), rectal cancer (8 percent), and refractory proctitis (28 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/61\">",
"     61",
"    </a>",
"    ]. The cumulative probability of developing rectal dysplasia at 5, 10, 15, and 20 years was 7, 9, 20, and 25 percent, respectively. The cumulative probability of developing rectal cancer at 5, 10, 15, and 20 years was 0, 2, 5, and 14 percent, respectively. The cumulative probability of having a functioning IRA at 10 and 20 years was 74 and 46 percent, respectively.",
"   </p>",
"   <p>",
"    Some patients with minimal rectal involvement may be suitable candidates for IRA, such as those who are not suitable for IPAA but who refuse an ileostomy or those who have medical conditions in which a stoma is relatively contraindicated (eg, portal hypertension or ascites). Some authors have advocated the operation in women of childbearing age to reduce the risk of infertility. The operation may also be a good choice for patients in whom Crohn's disease cannot be excluded or for patients with colitis complicated by advanced colonic malignancy.",
"   </p>",
"   <p>",
"    Satisfactory rectal function varies greatly depending upon the selections of patients and length of follow-up. The risk of cancer in the residual rectum has been reported to be 6 percent at 20 years and 15 percent at 30 years. The risk is significant considering that most patients are young and have many years to live.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H165136577\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best results from surgery occur in patients who have been well prepared medically and psychologically, and who undergo the surgery in a timely and expert fashion. Although the majority of patients with ulcerative colitis are young, they are often seriously ill in the emergent and urgent clinical settings. Complications are more likely in patients who are malnourished, immunosuppressed, depressed, or have infection. Thus, these features must be anticipated and recognized. The adequacy of nonsurgical therapy, the extent of disease, and previous operative and pathology reports must be reviewed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H165136584\">",
"    <span class=\"h2\">",
"     Optimization of medical status",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient's medical status should be optimized by correcting anemia, fluid depletion, electrolyte and acid-base disorders, and nutritional deficiencies. Many patients require",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    (TPN) and bowel rest because eating may worsen symptoms. However, long intervals of preoperative TPN are rarely justified, because it is difficult to demonstrate a significant impact on the ultimate outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/62\">",
"     62",
"    </a>",
"    ]. The simplest surgical corrective procedure should be performed in such severely compromised patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/32/6664?source=see_link\">",
"     \"Perioperative nutritional support\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Specific complications related to medications or coexisting diseases should be sought (",
"    <a class=\"graphic graphic_table graphicRef69570 \" href=\"UTD.htm?14/49/15132\">",
"     table 2",
"    </a>",
"    ). Nephrotoxicity and hepatotoxicity from medications such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    is a source of concern for most surgeons. Coagulopathy due to malnutrition or malabsorption should be corrected. The severity of liver disease should be assessed in patients with sclerosing cholangitis to assess surgical risk and optimize perioperative care. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12858?source=see_link\">",
"     \"Assessing surgical risk in patients with liver disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H165136591\">",
"    <span class=\"h2\">",
"     Immunosuppressive therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most immunosuppressive drugs can be discontinued just before surgery without sequelae, with the exception of corticosteroids, which must be tapered after surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/37/22103?source=see_link\">",
"     \"Glucocorticoid withdrawal\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17384?source=see_link\">",
"     \"The surgical patient taking glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    combined with other immunomodulators are not well studied. One small study found that patients with ulcerative colitis who received infliximab and cyclosporin before colectomy had increased morbidity compared with those who received infliximab alone [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/63\">",
"     63",
"    </a>",
"    ]. A multivariate analysis found infliximab to be the only factor independently associated with infectious complications in patients undergoing IPAA for chronic ulcerative colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/56\">",
"     56",
"    </a>",
"    ]. Preoperative use of infliximab may delay a potentially curative surgical procedure and increase the risk of serious postoperative complications. Therefore, a three-stage ileal pouch-anal canal anastomosis (IPAA) is the optimal approach for patients on combination immunosuppressive therapy that includes infliximab and requires surgical intervention.",
"   </p>",
"   <p>",
"    Prospective controlled trials with high quality data are needed to support the safety of immunosuppressive therapy in the perioperative period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H165136598\">",
"    <span class=\"h2\">",
"     Patient education",
"    </span>",
"    &nbsp;&mdash;&nbsp;An honest, straightforward discussion of the risks and benefits of the proposed operation with the patient and family is mandatory to avoid the frustrations of unrealistic expectations. The patient should understand the indications for surgery, the remaining medical options, the surgical alternatives, the expected outcome, and the potential for immediate and long-term complications of surgery. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?10/39/10869?source=see_link\">",
"     \"Patient information: Ulcerative colitis (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H165136605\">",
"    <span class=\"h2\">",
"     Ostomy site selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;If an ileostomy, either temporary or permanent, is planned, a stoma therapist should mark the abdominal site for the ileostomy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/12/28873?source=see_link&amp;anchor=H21062994#H21062994\">",
"     \"Surgical principles of ostomy construction\", section on 'Preoperative preparations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H165136612\">",
"    <span class=\"h2\">",
"     Mechanical bowel preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mechanical bowel preparation is not performed for patients undergoing small bowel procedures or in the clinical setting of an acute abdomen or acute fulminant colitis.",
"   </p>",
"   <p>",
"    While the evidence suggests that a mechanical bowel preparation is not required to safely perform a laparoscopic colectomy, many surgeons have not adopted this approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link&amp;anchor=H125365129#H125365129\">",
"     \"Surgical oncologic principles for the resection of colon cancer\", section on 'Mechanical bowel preparation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H165136619\">",
"    <span class=\"h2\">",
"     Antimicrobial prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/53/11094?source=see_link\">",
"     cefoxitin",
"    </a>",
"    , or ciprofloxan plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    are routinely administered (",
"    <a class=\"graphic graphic_table graphicRef65369 \" href=\"UTD.htm?23/52/24397\">",
"     table 3",
"    </a>",
"    ). We do not use oral antibiotics or continue prophylaxis postoperatively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18806?source=see_link\">",
"     \"Control measures to prevent surgical site infection following gastrointestinal procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H165136626\">",
"    <span class=\"h2\">",
"     Venous thromboembolism prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing a colectomy are at increased risk for thromboembolic venous and arterial complications [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. Thus, intermittent pneumatic compression",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    low dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    should be used prophylactically. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     LONG-TERM FUNCTIONAL RESULTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term success of surgical management depends upon the type of operation, the clinical setting, and surgical expertise. Several studies have suggested that functional results are poor during the long-term follow-up in patients who had adverse personality factors before surgery (such as problems with sexual satisfaction, difficulty expressing emotions, perfectionistic body ideals, and poor frustration tolerance) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/66\">",
"     66",
"    </a>",
"    ]. The following results were described in some of the largest series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One series included 1885 patients who underwent an ileal pouch-anal anastomosis for ulcerative colitis and were followed for an average of 11 years [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/67\">",
"       67",
"      </a>",
"      ]. The mean number of stools was 5.7 per day at one year and 6.4 at 20 years, and also increased at night from 1.5 to 2.0. The incidence of frequent fecal incontinence increased from 5 to 11 percent during the day and from 12 to 21 percent at night. The overall rate of pouch success at 5, 10, 15, and 20 years was 96, 93, 92, and 92 percent, respectively. Quality of life remained unchanged and 92 percent remained in the same employment.",
"     </li>",
"     <li>",
"      Anal canal strictures were described in up to 11 percent of 213 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/68\">",
"       68",
"      </a>",
"      ]. Nonfibrotic strictures generally responded well to anal dilation while fibrotic strictures were more commonly associated with intra- or postoperative complications and frequently required surgical therapy. In a series of 150 patients with ileal pouch strictures, endoscopic treatment of ileal pouch strictures appeared to be efficacious and generally safe to perform [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A systematic review of 43 observational studies (with a total of 9317 patients) found a pouch failure rate of 6.8 percent, increasing to 8.5 percent in those with more than five-year follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/70\">",
"       70",
"      </a>",
"      ]. Pelvic sepsis occurred in 9.5 percent. Severe, mild, and urge fecal incontinence was reported in 3.7, 17, and 7.3 percent, respectively. These results suggest that current techniques are associated with non-negligible complication rates and leave room for improvement and continued development of alternative procedures. Pelvic sepsis after IPAA is associated with a greater risk of failure as a consequence of surrounding pelvic fibrosis and limited pouch compliance [",
"      <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    IPAA may have long-term effects on female reproductive health [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/72\">",
"     72",
"    </a>",
"    ]. Some women experience increased dyspareunia [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/73\">",
"     73",
"    </a>",
"    ], although the ability to experience orgasm and coital frequency remain unchanged. Female fertility is significantly decreased [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/74\">",
"     74",
"    </a>",
"    ], possibly due to pelvic adhesions, although successful pregnancies occur regularly [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pregnancy and delivery are safe in patients with IPAA. Patients may experience a transient increase in stool frequency (including incontinence) during pregnancy, which resolves after delivery. Patients should not be discouraged from childbearing because of the pouch. Whether vaginal or cesarean delivery is better for women with a pelvic pouch remains controversial. The type of delivery should be influenced by obstetric consideration [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/76\">",
"     76",
"    </a>",
"    ] but also the potential risk of sphincter injury [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Satisfactory long-term functional outcome and excellent quality of life have also been described after stapled restorative proctocolectomy. In a series of 977 patients, quality of life increased for two years after surgery, with no deterioration thereafter [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/78\">",
"     78",
"    </a>",
"    ]. The prevalence of perfect continence increased from 76 percent before surgery to 82 percent after surgery and, although continence deteriorated somewhat more than two years after surgery, it was no worse than preoperative values. Ninety-eight percent of patients would have recommended the surgery to others. In another prospective, observational study, patients who had a stapled anastomosis had higher rates of daytime, nighttime, and complete continence compared with patients who underwent a hand-sewn anastomosis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, despite general patient satisfaction with preserved fecal continence, IPAA is associated with major long-term morbidity including a high pouch failure rate. In a review of 396 patients who had a pouch for longer than 15 years, regardless of the patient&rsquo;s age at the time of pouch creation, there was an increase in the incidence of incontinence and urgency over time, and with no substantial changes in dietary, social, employment, and sexual restrictions [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgeons must be experts not only to perform the operation well but also to detect and manage intraoperative, postoperative, and reoperative complications related to ileo-anal pouches [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/81\">",
"     81",
"    </a>",
"    ]. Immediate and short-term postoperative monitoring is performed to assess for complications that include anastomotic leaks, pelvic sepsis, fistula formation, portal vein thrombosis, and small bowel obstruction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/13/25818?source=see_link&amp;anchor=H7533556#H7533556\">",
"     \"Restorative proctocolectomy with ileal pouch-anal anastomosis: Laparoscopic approach\", section on 'Mortality and morbidity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All patients who undergo a colonic resection for ulcerative colitis should be monitored regularly for the development of long-term complications, including ultimate failure of the pouch and dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. Pelvic contrast MRI has proven to be invaluable for the diagnostic assessment of patients with clinically suspected pouch related complications, including leaks, and fistulae [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Dysplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of inflammatory changes in a retained rectal cuff, anal transitional zone, and ileal reservoir after stapled pouch-anal anastomosis is a cause of concern because of the long-term risk of dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. A systematic review of 23 observational and case control studies estimated that the prevalence of confirmed dysplasia in the pouch, anal transitional zone, or rectal cuff was 1.13 percent (range 0 to 19 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/86\">",
"     86",
"    </a>",
"    ]. The prevalence of high-grade, low-grade, or indefinite dysplasia was 0.15, 0.98, and 1.23 percent, respectively. Dysplasia was equally frequent in the pouch and rectal cuff or anal transitional zone. Dysplasia and cancer identified before or at operation were significant predictors of the development of dysplasia postoperatively [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/87\">",
"     87",
"    </a>",
"    ]. Pouchitis may also increase the risk of dysplasia as well [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of neoplasia is not completely eliminated by colectomy and mucosectomy. A retrospective review of 3203 patients with a preoperative diagnosis of ulcerative colitis who underwent restorative proctocolectomy found that the cumulative incidence for pouch neoplasia at 5, 10, 15, 20 and 25 years was 0.9, 1.3, 1.9, 4.2, and 5.1 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/87\">",
"     87",
"    </a>",
"    ]. Eleven patients developed adenocarcinoma of the pouch or at the anal transitional zone, one developed lymphoma in the pouch, three developed squamous cell carcinoma at the anal transitional zone, and 23 developed pouch dysplasia. The prognosis of pouch adenocarcinoma appeared to be poor.",
"   </p>",
"   <p>",
"    While surveillance in patients with retained colonic mucosa should be performed, the optimal frequency of pouch endoscopy and biopsy is not well established. Data from the UK National Pouch Audit Programme, which is actively recruiting patients, may help to set guidelines for appropriate monitoring (Ileal Pouch Registry &ndash; Association of Coloproctology of Great Britain and Ireland 2011.",
"    <a class=\"external\" href=\"file://www.acpgbi.org.uk/research/ileal\">",
"     file://www.acpgbi.org.uk/research/ileal",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One author recommends performing an initial screening five years after creation of an ileal pouch in children or when the total disease duration exceeds seven years [",
"    <a class=\"abstract\" href=\"UTD.htm?4/50/4906/abstract/90\">",
"     90",
"    </a>",
"    ]. It is reasonable to increase the frequency of surveillance in patients with chronic pouchitis who have severe villous atrophy and in patients who had dysplasia in the resected colon or rectum. Resection of the ileal pouch and anal canal should be considered in patients with pouch or anal high-grade dysplasia detected during surveillance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/9/38034?source=see_link\">",
"       \"Patient information: Colectomy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?10/39/10869?source=see_link\">",
"       \"Patient information: Ulcerative colitis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7411991\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Advances in medical therapy, including use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      , have reduced catastrophic complications from ulcerative colitis, such as massive hemorrhage, perforation, fulminant colitis, and acute colonic obstruction as well as the need for an emergent total colectomy resection. Restorative proctocolectomy with ileal pouch-anal anastomosis is the preferred approach for patients for whom medical therapy has been unsuccessful in controlling symptoms or is undesirable. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Indications for operative management'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/13/25818?source=see_link\">",
"       \"Restorative proctocolectomy with ileal pouch-anal anastomosis: Laparoscopic approach\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute fulminant colitis with an acute abdomen is an absolute indication for a total abdominal colectomy and end ileostomy. Typically, a total colectomy is performed and the rectum is managed as a mucous fistula or Hartmann procedure. (See",
"      <a class=\"local\" href=\"#H6558011\">",
"       'Emergent clinical settings'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H96428458\">",
"       'Acute setting procedures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who present with acute fulminate colitis without an acute abdomen, we perform an emergent total colectomy if the clinical setting worsens after a trial of medical therapy. (See",
"      <a class=\"local\" href=\"#H1203394\">",
"       'Acute fulminant colitis without acute abdomen'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the elective setting following failed medical therapy or as a prophylactic procedure, we perform a restorative proctocolectomy with an ileal pouch-anal anastomosis (RPC-IPAA). For patients who are elderly, have poor sphincter function, significant comorbid disease,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      concurrent rectal cancer, a laparoscopic &ldquo;incisionless&rdquo; total proctocolectomy with an end ileostomy is the optimal option. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Elective setting procedures'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/13/25818?source=see_link\">",
"       \"Restorative proctocolectomy with ileal pouch-anal anastomosis: Laparoscopic approach\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/1\">",
"      Cima RR, Pemberton JH. Medical and surgical management of chronic ulcerative colitis. Arch Surg 2005; 140:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/2\">",
"      Sanders DS. The differential diagnosis of Crohn's disease and ulcerative colitis. Baillieres Clin Gastroenterol 1998; 12:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/3\">",
"      Tanaka M, Riddell RH, Saito H, et al. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Scand J Gastroenterol 1999; 34:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/4\">",
"      Andersson P, Olaison G, Hallb&ouml;&ouml;k O, Sj&ouml;dahl R. Segmental resection or subtotal colectomy in Crohn's colitis? Dis Colon Rectum 2002; 45:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/5\">",
"      Reese GE, Lovegrove RE, Tilney HS, et al. The effect of Crohn's disease on outcomes after restorative proctocolectomy. Dis Colon Rectum 2007; 50:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/6\">",
"      Swan NC, Geoghegan JG, O'Donoghue DP, et al. Fulminant colitis in inflammatory bowel disease: detailed pathologic and clinical analysis. Dis Colon Rectum 1998; 41:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/7\">",
"      Yu CS, Pemberton JH, Larson D. Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results. Dis Colon Rectum 2000; 43:1487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/8\">",
"      Delaney CP, Remzi FH, Gramlich T, et al. Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis. Ann Surg 2002; 236:43.",
"     </a>",
"    </li>",
"    <li>",
"     Stark, ME, Tremaine, WJ. Medical care of the inflammatory bowel disease patients. In: The Gastrointestinal Surgical Patient: Preoperative and Post Operative Care, Quigley, EM, Sorrell, MR (Eds), Williams &amp; Williams, Baltimore 1994. p.411.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/10\">",
"      Bodzin JH, Klein SN, Priest SG. Ileoproctostomy is preferred over ileoanal pull-through in patients with indeterminate colitis. Am Surg 1995; 61:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/11\">",
"      Geboes K, Colombel JF, Greenstein A, et al. Indeterminate colitis: a review of the concept--what's in a name? Inflamm Bowel Dis 2008; 14:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/12\">",
"      Melton GB, Kiran RP, Fazio VW, et al. Do preoperative factors predict subsequent diagnosis of Crohn's disease after ileal pouch-anal anastomosis for ulcerative or indeterminate colitis? Colorectal Dis 2010; 12:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/13\">",
"      Mortellaro VE, Green J, Islam S, et al. Occurrence of Crohn's disease in children after total colectomy for ulcerative colitis. J Surg Res 2011; 170:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/14\">",
"      Goudet P, Dozois RR, Kelly KA, et al. Changing referral patterns for surgical treatment of ulcerative colitis. Mayo Clin Proc 1996; 71:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/15\">",
"      Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992; 103:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/16\">",
"      Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990; 31:329.",
"     </a>",
"    </li>",
"    <li>",
"     www.thelancet.com Published online August 20, 2012 file://dx.doi.org/10.1016/S0140-6736(12)60150-0.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/18\">",
"      Cohen RD. How should we treat severe acute steroid-refractory ulcerative colitis? Inflamm Bowel Dis 2009; 15:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/19\">",
"      Halfvarson J, J&auml;rnerot G. Treatment of choice for acute severe steroid-refractory ulcerative colitis is remicade. Inflamm Bowel Dis 2009; 15:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/20\">",
"      Becker JM, Stucchi AF. Treatment of choice for acute severe steroid-refractory ulcerative colitis is colectomy. Inflamm Bowel Dis 2009; 15:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/21\">",
"      Randall J, Singh B, Warren BF, et al. Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications. Br J Surg 2010; 97:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/22\">",
"      Sachar DB. Management of acute, severe ulcerative colitis. J Dig Dis 2012; 13:65.",
"     </a>",
"    </li>",
"    <li>",
"     Hurst, R.D., et al., Prospective analysis of perioperative morbidity in one hundred consecutive colectomies for ulcerative colitis. Surgery, 1995. 118(4): p. 748-754.",
"    </li>",
"    <li>",
"     Greenstein, A.J., et al., Outcome of toxic dilatation in ulcerative and Crohn's colitis. J.Clin.Gastroenterol., 1985. 7(2): p. 137-143.",
"    </li>",
"    <li>",
"     Robert, J.R., D.B. Sachar, and A.J. Greenstein, Severe gastrointestinal hemorrhage in Crohn's disease. Ann Surg, 1991. 213(3): p. 207-11.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/26\">",
"      Hurst RD, Finco C, Rubin M, Michelassi F. Prospective analysis of perioperative morbidity in one hundred consecutive colectomies for ulcerative colitis. Surgery 1995; 118:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/27\">",
"      J&auml;rnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005; 128:1805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/28\">",
"      Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353:2462.",
"     </a>",
"    </li>",
"    <li>",
"     Ekbom, A., et al., Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med, 1990. 323(18): p. 1228-33.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/30\">",
"      Gorfine SR, Bauer JJ, Harris MT, Kreel I. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted? Dis Colon Rectum 2000; 43:1575.",
"     </a>",
"    </li>",
"    <li>",
"     Bernstein, C.N., F. Shanahan, and W.M. Weinstein, Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet, 1994. 343(8889): p. 71-4.",
"    </li>",
"    <li>",
"     Ullman, T., et al., Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology, 2003. 125(5): p. 1311-9.",
"    </li>",
"    <li>",
"     Ullman, T.A., et al., The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol, 2002. 97(4): p. 922-7.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/34\">",
"      Kisiel JB, Loftus EV Jr, Harmsen WS, et al. Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy. Inflamm Bowel Dis 2012; 18:226.",
"     </a>",
"    </li>",
"    <li>",
"     Michelassi, F. Indications for surgical treatment in ulcerative colitis and Crohn's disease. In: Operative Strategies in Inflammatory Bowel Disease, Michelassi, F, Milson, JW (Eds), Springer, 1997. p.151.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/36\">",
"      Heyries L, Bernard JP, Perrier H, et al. [Hemorrhagic rectocolitis and autoimmune hemolytic anemia]. Gastroenterol Clin Biol 1998; 22:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/37\">",
"      Goudet P, Dozois RR, Kelly KA, et al. Characteristics and evolution of extraintestinal manifestations associated with ulcerative colitis after proctocolectomy. Dig Surg 2001; 18:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/38\">",
"      Holubar SD, Larson DW, Dozois EJ, et al. Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach? Dis Colon Rectum 2009; 52:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/39\">",
"      Hult&eacute;n L. Proctocolectomy and ileostomy to pouch surgery for ulcerative colitis. World J Surg 1998; 22:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/40\">",
"      McLeod, RS. Quality of life after surgery for ulcerative colitis. Problems in General Surgery 1999; 16:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/41\">",
"      Dolgin SE, Shlasko E, Gorfine S, et al. Restorative proctocolectomy in children with ulcerative colitis utilizing rectal mucosectomy with or without diverting ileostomy. J Pediatr Surg 1999; 34:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/42\">",
"      Remzi FH, Fazio VW, Gorgun E, et al. The outcome after restorative proctocolectomy with or without defunctioning ileostomy. Dis Colon Rectum 2006; 49:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/43\">",
"      Larson DW, Dozois EJ, Piotrowicz K, et al. Laparoscopic-assisted vs. open ileal pouch-anal anastomosis: functional outcome in a case-matched series. Dis Colon Rectum 2005; 48:1845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/44\">",
"      Wexner SD, Johansen OB, Nogueras JJ, Jagelman DG. Laparoscopic total abdominal colectomy. A prospective trial. Dis Colon Rectum 1992; 35:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/45\">",
"      Shore G, Gonzalez QH, Bondora A, Vickers SM. Laparoscopic vs conventional ileocolectomy for primary Crohn disease. Arch Surg 2003; 138:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/46\">",
"      Marceau C, Alves A, Ouaissi M, et al. Laparoscopic subtotal colectomy for acute or severe colitis complicating inflammatory bowel disease: a case-matched study in 88 patients. Surgery 2007; 141:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/47\">",
"      Poritz LS, Koltun WA. Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis. Dis Colon Rectum 2003; 46:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/48\">",
"      Polle SW, Dunker MS, Slors JF, et al. Body image, cosmesis, quality of life, and functional outcome of hand-assisted laparoscopic versus open restorative proctocolectomy: long-term results of a randomized trial. Surg Endosc 2007; 21:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/49\">",
"      Geisler DP, Kirat HT, Remzi FH. Single-port laparoscopic total proctocolectomy with ileal pouch-anal anastomosis: initial operative experience. Surg Endosc 2011; 25:2175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/50\">",
"      Gash KJ, Goede AC, Kaldowski B, et al. Single incision laparoscopic (SILS) restorative proctocolectomy with ileal pouch-anal anastomosis. Surg Endosc 2011; 25:3877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/51\">",
"      Leblanc F, Makhija R, Champagne BJ, Delaney CP. Single incision laparoscopic total colectomy and proctocolectomy for benign disease: initial experience. Colorectal Dis 2011; 13:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/52\">",
"      Pedraza R, Patel CB, Ramos-Valadez DI, Haas EM. Robotic-assisted laparoscopic surgery for restorative proctocolectomy with ileal J pouch-anal anastomosis. Minim Invasive Ther Allied Technol 2011; 20:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/53\">",
"      Indar AA, Efron JE, Young-Fadok TM. Laparoscopic ileal pouch-anal anastomosis reduces abdominal and pelvic adhesions. Surg Endosc 2009; 23:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/54\">",
"      Hull TL, Joyce MR, Geisler DP, Coffey JC. Adhesions after laparoscopic and open ileal pouch-anal anastomosis surgery for ulcerative colitis. Br J Surg 2012; 99:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/55\">",
"      Yokoyama T, Masaki T, Ono M, et al. Per anal suturing of a bleeding ulcer to achieve successful hemostasis of massive hemorrhage associated with ulcerative colitis: report of two cases. Surg Today 1998; 28:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/56\">",
"      Selvasekar CR, Cima RR, Larson DW, et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007; 204:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/57\">",
"      Fichera A, Zoccali M, Gullo R. Single incision (\"scarless\") laparoscopic total abdominal colectomy with end ileostomy for ulcerative colitis. J Gastrointest Surg 2011; 15:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/58\">",
"      Holubar SD, Privitera A, Cima RR, et al. Minimally invasive total proctocolectomy with Brooke ileostomy for ulcerative colitis. Inflamm Bowel Dis 2009; 15:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/59\">",
"      Browning SM, Nivatvongs S. Intraoperative abandonment of ileal pouch to anal anastomosis--the Mayo Clinic experience. J Am Coll Surg 1998; 186:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/60\">",
"      Chun HK, Smith LE, Orkin BA. Intraoperative reasons for abandoning ileal pouch-anal anastomosis procedures. Dis Colon Rectum 1995; 38:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/61\">",
"      da Luz Moreira A, Kiran RP, Lavery I. Clinical outcomes of ileorectal anastomosis for ulcerative colitis. Br J Surg 2010; 97:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/62\">",
"      Dayton, MT.  Preoperative and postoperative care of patients with inflammatory bowel disease. Problems in General Surgery 1999; 16:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/63\">",
"      Schluender SJ, Ippoliti A, Dubinsky M, et al. Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis? Dis Colon Rectum 2007; 50:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/64\">",
"      Schapira M, Henrion J, Ravoet C, et al. Thromboembolism in inflammatory bowel disease. Acta Gastroenterol Belg 1999; 62:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/65\">",
"      Irving PM, Pasi KJ, Rampton DS. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 2005; 3:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/66\">",
"      Weinryb RM, Gustavsson JP, Barber JP. Personality predictors of dimensions of psychosocial adjustment after surgery. Psychosom Med 1997; 59:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/67\">",
"      Hahnloser D, Pemberton JH, Wolff BG, et al. Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg 2007; 94:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/68\">",
"      Prudhomme M, Dozois RR, Godlewski G, et al. Anal canal strictures after ileal pouch-anal anastomosis. Dis Colon Rectum 2003; 46:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/69\">",
"      Shen B, Lian L, Kiran RP, et al. Efficacy and safety of endoscopic treatment of ileal pouch strictures. Inflamm Bowel Dis 2011; 17:2527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/70\">",
"      Hueting WE, Buskens E, van der Tweel I, et al. Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients. Dig Surg 2005; 22:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/71\">",
"      Kiely JM, Fazio VW, Remzi FH, et al. Pelvic sepsis after IPAA adversely affects function of the pouch and quality of life. Dis Colon Rectum 2012; 55:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/72\">",
"      Wax JR, Pinette MG, Cartin A, Blackstone J. Female reproductive health after ileal pouch anal anastomosis for ulcerative colitis. Obstet Gynecol Surv 2003; 58:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/73\">",
"      Cornish JA, Tan E, Teare J, et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum 2007; 50:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/74\">",
"      Johnson P, Richard C, Ravid A, et al. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2004; 47:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/75\">",
"      Hahnloser D, Pemberton JH, Wolff BG, et al. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis Colon Rectum 2004; 47:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/76\">",
"      Juhasz ES, Fozard B, Dozois RR, et al. Ileal pouch-anal anastomosis function following childbirth. An extended evaluation. Dis Colon Rectum 1995; 38:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/77\">",
"      Remzi FH, Gorgun E, Bast J, et al. Vaginal delivery after ileal pouch-anal anastomosis: a word of caution. Dis Colon Rectum 2005; 48:1691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/78\">",
"      Fazio VW, O'Riordain MG, Lavery IC, et al. Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg 1999; 230:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/79\">",
"      Michelassi F, Lee J, Rubin M, et al. Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study. Ann Surg 2003; 238:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/80\">",
"      Kiran RP, El-Gazzaz G, Remzi FH, et al. Influence of age at ileoanal pouch creation on long-term changes in functional outcomes. Colorectal Dis 2011; 13:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/81\">",
"      Sagar PM, Pemberton JH. Intraoperative, postoperative and reoperative problems with ileoanal pouches. Br J Surg 2012; 99:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/82\">",
"      Horgan, AF, Pemberton, JH. Long-term follow-up for ulcerative colitis. Problems in General Surgery 1999; 16:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/83\">",
"      Tonolini M, Campari A, Bianco R. Ileal pouch and related complications: spectrum of imaging findings with emphasis on MRI. Abdom Imaging 2011; 36:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/84\">",
"      Goldman H. Pouch dysplasia: a new challenge. Inflamm Bowel Dis 1998; 4:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/85\">",
"      Ziv Y, Fazio VW, Sirimarco MT, et al. Incidence, risk factors, and treatment of dysplasia in the anal transitional zone after ileal pouch-anal anastomosis. Dis Colon Rectum 1994; 37:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/86\">",
"      Scarpa M, van Koperen PJ, Ubbink DT, et al. Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis. Br J Surg 2007; 94:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/87\">",
"      Kariv R, Remzi FH, Lian L, et al. Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy. Gastroenterology 2010; 139:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/88\">",
"      Banasiewicz T, Marciniak R, Paszkowski J, et al. Pouchitis may increase the risk of dysplasia after restorative proctocolectomy in patients with ulcerative colitis. Colorectal Dis 2012; 14:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/89\">",
"      Haboubi N. Dysplasia in the ileal pouch revisited: what does it mean and what does it imply? Colorectal Dis 2012; 14:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/50/4906/abstract/90\">",
"      Sarigol S, Wyllie R, Gramlich T, et al. Incidence of dysplasia in pelvic pouches in pediatric patients after ileal pouch-anal anastomosis for ulcerative colitis. J Pediatr Gastroenterol Nutr 1999; 28:429.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1375 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-CCD5015BA2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4906=[""].join("\n");
var outline_f4_50_4906=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7411991\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DISTINGUISHING BETWEEN ULCERATIVE COLITIS AND CROHN'S DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      INDICATIONS FOR OPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6558011\">",
"      Emergent clinical settings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6558083\">",
"      - Acute fulminant colitis with acute abdomen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1203357\">",
"      Urgent clinical settings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1203394\">",
"      - Acute fulminant colitis without acute abdomen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6558357\">",
"      Elective clinical settings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H165136371\">",
"      - Risk reduction for colon and rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3875966\">",
"      - Precancerous lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6557946\">",
"      - Intractable disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2171787\">",
"      - Indeterminate colitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Extraintestinal manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H165136853\">",
"      TYPES OF SURGICAL PROCEDURES BASED UPON CLINICAL SETTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96428458\">",
"      Acute setting procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Elective setting procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H165136577\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H165136584\">",
"      Optimization of medical status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H165136591\">",
"      Immunosuppressive therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H165136598\">",
"      Patient education",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H165136605\">",
"      Ostomy site selection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H165136612\">",
"      Mechanical bowel preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H165136619\">",
"      Antimicrobial prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H165136626\">",
"      Venous thromboembolism prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      LONG-TERM FUNCTIONAL RESULTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      POSTOPERATIVE MONITORING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7411991\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/1375\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/1375|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/49/20247\" title=\"figure 1\">",
"      Surg ulcerative colitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/1375|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/62/7148\" title=\"table 1\">",
"      Surgical options for UC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/49/15132\" title=\"table 2\">",
"      Periop complix from IBD meds",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/52/24397\" title=\"table 3\">",
"      Antimicrobial prophylaxis for gastrointestinal surgery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12858?source=related_link\">",
"      Assessing surgical risk in patients with liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20490?source=related_link\">",
"      Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11386?source=related_link\">",
"      Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/7/25722?source=related_link\">",
"      Colorectal cancer surveillance in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18806?source=related_link\">",
"      Control measures to prevent surgical site infection following gastrointestinal procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/37/22103?source=related_link\">",
"      Glucocorticoid withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/4/44105?source=related_link\">",
"      Infliximab in Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3319?source=related_link\">",
"      Management of severe ulcerative colitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/29/38361?source=related_link\">",
"      Operative management of Crohn's disease of the small bowel and colon",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19305?source=related_link\">",
"      Overview of the medical management of mild to moderate Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/9/38034?source=related_link\">",
"      Patient information: Colectomy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?10/39/10869?source=related_link\">",
"      Patient information: Ulcerative colitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/32/6664?source=related_link\">",
"      Perioperative nutritional support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/13/25818?source=related_link\">",
"      Restorative proctocolectomy with ileal pouch-anal anastomosis: Laparoscopic approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=related_link\">",
"      Surgical oncologic principles for the resection of colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/12/28873?source=related_link\">",
"      Surgical principles of ostomy construction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17384?source=related_link\">",
"      The surgical patient taking glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/30/18920?source=related_link\">",
"      Toxic megacolon",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_50_4907="Essential clinician tasks";
var content_f4_50_4907=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F53207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F53207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Essential tasks of the contemporary clinician",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Comprehend the biomedical and psychosocial knowledge base pertinent to your field of medicine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Develop a personal strategy to learn continuously and manage the rapid changes in this information",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Connect in a personal, professional manner with each patient who seeks care from you",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Understand the healthcare delivery system in which you work, and your role in it",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Act in ways that maximize the cost-effectiveness and healing influences of the healthcare you provide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Educate and support your patients in the optimal use of the healthcare system",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4907=[""].join("\n");
var outline_f4_50_4907=null;
var title_f4_50_4908="MHC class II deficiency";
var content_f4_50_4908=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F57419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F57419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for MHC-class II deficiency",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Definitive diagnosis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Male or female patient with decreased intensity of expression (less than 5 percent of normal) of HLA-DR or DP on B cells or monocytes and a mutation in one of the following genes: CIITA, RFX-B, RFX-5, or RFX-AP.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Probable diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Male or female patient with",
"decreased intensity of expression (less than 5 percent of normal) of",
"HLA-DR or DP on B cells and monocytes and all of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Failure to thrive, opportunistic infections, or persistent viral infections.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Normal numbers of T cells and B cells.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. Normal proliferative responses to mitogens.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Possible diagnosis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Male or female patient with",
"decreased intensity of expression (less than 5 percent of normal) of",
"HLA-DR or DP on B cells or monocytes, and normal numbers of T cells and",
"B cells, who has at least one of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Hypogammaglobulinemia.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Normal mitogen responses but absent T-cell proliferation to",
"antigens.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. Reduced numbers of CD4+ cells.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        4. Failure of mononuclear",
"cells to stimulate a mixed lymphocyte culture.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Patients with a definitive or probable diagnosis are assumed to have a greater than 98 and 85 percent probability, respectively, that in 20 years they will still have the same diagnosis. Patients with a possible diagnosis are those that have some but not all of the characteristic clinical or laboratory findings of a particular disorder.",
"    </div>",
"    <div class=\"reference\">",
"     From Conley, ME, Notarangelo, LD, Etzioni, A. Clin Immunol 1999; 93:190.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4908=[""].join("\n");
var outline_f4_50_4908=null;
var title_f4_50_4909="Examining the peripheral smear";
var content_f4_50_4909=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F52991&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F52991&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    How to examine the peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 419px; height: 210px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This schematic depicts a well-made peripheral blood smear. A drop of blood has been placed on the left-hand side of a clean glass slide at point A, and has been pulled towards the right-hand side using another glass slide, stopping at point B. The area near point A is too thick and too darkly stained for interpretation, whereas the area at the very end of the smear, near point B (the \"feather edge\") is too thin, distorting the morphology of all cells in that area. The optimal area for viewing is just behind point B (shown by the asterisk), in an area where the red blood cells are just touching and demonstrate central pallor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4909=[""].join("\n");
var outline_f4_50_4909=null;
var title_f4_50_4910="Gold compounds";
var content_f4_50_4910=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F58824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F58824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Molecular preparations of gold",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 402px; height: 401px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gold sodium thiomalate and aurothioglucose, the two intramuscular gold preparations most widely used in the United States, are aurous salts, contain 50 percent gold by weight, and are attached to a sulfure moiety. Auranofin, a conjugated gold compound with two ligands, contains sulfur and is 29 percent gold by weight.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Duncan Gordon, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_50_4910=[""].join("\n");
var outline_f4_50_4910=null;
var title_f4_50_4911="Contents: Gastrointestinal infections";
var content_f4_50_4911=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?15/21/15710\">",
"       Infectious Diseases",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Gastrointestinal infections",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Gastrointestinal infections",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Abdominal abscesses",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/53/29526\">",
"           Pyogenic liver abscess",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Biliary",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/29/26069\">",
"           AIDS cholangiopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/13/24790\">",
"           Acute cholangitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/6/42087\">",
"           Endoscopic diagnosis and management of biliary parasitosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Bowel",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/35/38452\">",
"           Abdominal actinomycosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/17/32025\">",
"           Approach to the adult with acute diarrhea in developed countries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/17/29976\">",
"           Approach to the adult with acute diarrhea in developing countries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/31/5625\">",
"           Approach to the child with acute diarrhea in developing countries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/8/26761\">",
"           Approach to the patient with nontyphoidal Salmonella in a stool culture",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/44/1736\">",
"           Clinical manifestations and diagnosis of Listeria monocytogenes infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/40/38535\">",
"           Clinical manifestations and diagnosis of Shigella infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/57/14232\">",
"           Clinical manifestations, diagnosis and treatment of enterohemorrhagic Escherichia coli (EHEC) infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/19/19769\">",
"           Clinical manifestations, diagnosis, and treatment of Campylobacter infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/48/26376\">",
"           Clinical presentation and diagnosis of rotavirus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/33/21015\">",
"           Clostridium difficile and probiotics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/39/29305\">",
"           Clostridium difficile in adults: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/18/36137\">",
"           Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/29/20954\">",
"           Clostridium difficile in adults: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/48/31493\">",
"           Cyclospora infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/44/24265\">",
"           Differential diagnosis of microbial foodborne disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/46/26345\">",
"           Epidemiology and causes of acute diarrhea in developed countries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/10/6313\">",
"           Epidemiology of viral gastroenteritis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/14/43241\">",
"           Epidemiology, clinical manifestations and diagnosis of norovirus and related viruses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/40/13961\">",
"           Epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/28/33224\">",
"           Epidemiology, clinical manifestations, and diagnosis of giardiasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/1/42008\">",
"           Epidemiology, microbiology, and pathogenesis of Shigella infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/2/42024\">",
"           Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/58/19368\">",
"           Infection with less common Campylobacter species and related bacteria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/19/14649\">",
"           Microbiology and epidemiology of salmonellosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/60/5065\">",
"           Microbiology, pathogenesis, and epidemiology of Campylobacter infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/19/18745\">",
"           Microbiology, pathogenesis, epidemiology, and prevention of enterohemorrhagic Escherichia coli (EHEC)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/45/16089\">",
"           Microsporidiosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/14/36073\">",
"           Overview of Vibrio cholerae infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/37/19033\">",
"           Pathogenesis of Salmonella gastroenteritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/4/29768\">",
"           Pathogenesis of Vibrio cholerae infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/6/21607\">",
"           Pathogenesis of typhoid fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/4/37960\">",
"           Pathogenic Escherichia coli",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/57/12184\">",
"           Prevention and control of Clostridium difficile in hospital and institutional settings",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/27/18868\">",
"           Prevention and treatment of viral gastroenteritis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/29/29145\">",
"           Travelers' diarrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/26/39334\">",
"           Treatment and prevention of Shigella infection in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/40/1670\">",
"           Treatment and prevention of cryptosporidiosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/58/18345\">",
"           Treatment and prevention of typhoid fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/46/745\">",
"           Treatment, prognosis, and prevention of Listeria monocytogenes infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/53/43862\">",
"           Tuberculous enteritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/31/27125\">",
"           Typhlitis (neutropenic enterocolitis)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/33/32274\">",
"           Clinical microbiology review: Gastrointestinal infections",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other GI infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/30/33254\">",
"           Pylephlebitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/35/11833\">",
"           Whipple's disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Peritoneal",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/5/22617\">",
"           Clinical manifestations and diagnosis of peritonitis in peritoneal dialysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/0/7172\">",
"           Clinical manifestations of spontaneous bacterial peritonitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/0/12296\">",
"           Diagnosis of spontaneous bacterial peritonitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/11/17594\">",
"           Microbiology and therapy of peritonitis in continuous peritoneal dialysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/25/34197\">",
"           Pathogenesis of spontaneous bacterial peritonitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/40/26248\">",
"           Pathophysiology and prevention of peritonitis in peritoneal dialysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/1/4121\">",
"           Treatment and prophylaxis of spontaneous bacterial peritonitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/60/3018\">",
"           Tunnel and peritoneal catheter exit site infections in continuous peritoneal dialysis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Viral infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/49/34585\">",
"           Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/14/43241\">",
"           Epidemiology, clinical manifestations and diagnosis of norovirus and related viruses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/26/41383\">",
"           Epidemiology, pathogenesis, treatment, and prevention of enterovirus and parechovirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/26/7591\">",
"           Overview of hepatitis A virus infection in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/52/17223\">",
"           Poliovirus vaccination",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-457B94F74C-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f4_50_4911=[""].join("\n");
var outline_f4_50_4911=null;
